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ABSTRACT 
The objective of this thesis was to understand the ICP8 protein interactions 
involved during the formation of HSV-1 replication compartments. We focused 
our efforts on mapping the ICP8-ICP8 self-interactions that are involved in the 
formation of DNA independent filaments. We report here that the FNF motif 
(F1142, N1143 and F1144) and the FW motif (F843 and W844) are essential for 
ICP8 filament formation. Furthermore we observed a positive correlation between 
ICP8 filamentation and the formation of replication compartments. Mammalian 
expression plasmids bearing mutations in these motifs (FNF and FW) were 
unable to complement an ICP8 null virus for growth and replication compartment 
formation. We propose that filaments or other higher order structures of ICP8 
may provide a scaffold onto which other proteins are recruited to form 
prereplicative sites and replication compartments. In an attempt to broaden our 
understanding of ICP8 self-interactions and its interactions with other essential 
viral proteins we searched for potential protein interaction sites on the surface of 
ICP8.  Using the structural information of ICP8 and sequence comparison with 
homologous proteins, we identified conserved residues in the shoulder region 
(R262, H266, D270, E271, E274, Q706 and F707) of ICP8 that might function as 
protein interaction sites.  The Q706A and F707A (QF) mutant protein was able to 
Anthar S. Darwish, PhD 
University of Connecticut, 2018
form pre-replicative like sites and bind ssDNA but cannot complement ICP8 null 
virus for growth and replication compartment formation. Our analysis suggests 
that (QF) is involved in an important function or interaction that is required for the 
progression of mature replication compartments.  
Anthar S. Darwish, University of Connecticut, 2018
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                                                   Chapter 1 
                                                 Introduction 
 
1.1 Human Herpesviridea Overview 
 
Herpesviridae, or more commonly called Herpesviruses, is a family of more than 
200 large double stranded DNA (dsDNA) viruses that infect a wide range of hosts 
including mammals, birds and reptiles. The family name originates from the Greek word 
herpein, “to creep”, due to the latent infections and periodic reactivations that are 
characteristic of this group. Herpesviruses first evolved nearly 500 million years ago and 
since the dawn of human evolution have been infecting and co-evolving with our 
species. To date, nine Herpesviruses have been identified that infect humans, they are 
further classified into three-subfamilies (Alphaherpesvirus, Betaherpesvirus, and 
Gammaherpesvirus) based on tissue tropism of infection and lengths of replicative 
cycles (Pellett and Roizman 2013). More than 90% of the human population has been 
infected with one or more of these viruses (Looker et al. 2015; Chayavichitsilp et al. 
2009).  
 
 The human Herpesviruses share several common characteristics. The members of this 
family all encode a large number of viral proteins involved in nucleic acid metabolism. 
They also use the cellular nucleus as the site of virus gene transcription, synthesis of 
viral DNA and nucleocapsid assembly. Furthermore, Herpesviruses use latency as a 
mechanism to establish lifelong persistency with their hosts and periodically reactivate 
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to the lytic cycle to produce progeny virions. Lytic infection usually leads to destruction 
in non-neuronal infected cells. However, the Herpesviruses also differ vastly with 
regards to tissue tropism of infection, lengths of replicative cycles and the mechanisms 
they employ for evading host response and disease manifestation (Pellett and Roizman 
2013).  
The human Alphaherpesviruses have shorter replicative cycles than the Beta and 
Gamma viruses and establish latency in neuronal tissue. This family consists of Herpes 
Simplex virus type 1 (HSV-1), Herpes Simplex virus type 2 (HSV-2) and Varicella Zoster 
Virus (VZV). HSV-1 and HSV-2 are the causative agents for primary and recurrent oral 
and genital herpetic lesions. These types of lesions are usually non-lethal although they 
may cause life-threatening ocular and nervous system infections in 
immunocompromised individuals and newborns. Occasionally, HSV-1 can also cause 
corneal infections and encephalitis. HSV-1 and HSV-2 infections can increase the 
infection rates of more serious pathogens such as HIV and HPV (Corey et al. 2004; 
Szostek, Zawilinska, and Kopec 2009). VZV is the infectious agent responsible for 
chicken pox and shingles (Roizman, Knipe, and Whitley 2013).  
The Betaherpesvirus establish latency in lymphocytes, secretory glands, kidneys, and 
other tissues. This subfamily includes Human Cytomegalovirus (HCMV), which is 
usually non problematic in healthy individuals although it can be life-threatening for 
immunocompromised patients, particularly organ transplant recipients (Pellett and 
Roizman 2013). HCMV also causes a range of congenital abnormalities and is the 
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leading infectious cause of deafness and intellectual disabilities in children (Damato and 
Winnen 2002). Other members of the Betaherpesvirus subfamily have not been as 
extensively studied as HCMV. The HHV-6B and HHV-7 viruses are known to be the 
causative agents of roseola infection in children. HHV-7 has also been known to cause 
Febrile Respiratory disease (Yamanishi and Mori 2009; Yamanishi, Mori, and Pellett 
2013). Additionally, HHV-6A and/or HHV-6B may be linked to the pathogenesis of 
Multiple Sclerosis (Leibovitch and Jacobson 2014).  
The Gammaherpesviruses have a narrow host cell range. They usually infect either T or 
B-lymphocytes and establish latency in lymphoid tissue (Pellett and Roizman 2013).
This subfamily of viruses includes Epstein-Barr virus (EBV) and Kaposi’s sarcoma 
associated Herpesvirus (KSHV). EBV is the causative agent of mononucleosis and also 
has the ability to transform B-lymphocytes and is linked to several malignant diseases, 
such as Burkitt’s lymphoma and Hodgkin’s lymphoma (Longnecker, Kieff, and Cohen 
2013).  KSHV infections are the most widely spread cause of cancer in acquired 
immunodeficiency syndrome (AIDS) patients (Damania and Cesarman 2013).  
1.2 HSV-1 Virion 
The morphological characteristics of an HSV-1 virion are similar among all members of 
the Herpesviruses family. The key function of the virion is to protect the viral genome 
and to act as an infection transmission vehicle. A mature virion is approximately 200nm 
in diameter and contains a DNA core that is harbored in an icosahedral proteinaceous  
3
Adapted from M. K. Kukhanoval et.al, 2014
 Figure 1.1 HSV-1 Virion. A mature virion is approximately 200nm
 in diameter and contains a DNA core that is harbored in an
 icosahedral proteinaceous capsid. Surrounding the nucleocapsid
 is a layer of viral proteins called the tegument; all of these 
 components are enclosed in a lipid bilayer envelope. 
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capsid. Surrounding the nucleocapsid is a layer of viral proteins called the tegument; all 
of these components are enclosed in a lipid bilayer envelope (Figure 1.1).  
HSV-1 Genome 
The HSV-1 genome is a linear double stranded 152-kbp DNA molecule with nicks and 
gaps (Kieff, Bachenheimer, and Roizman 1971; McGeoch et al. 1988; S. Smith et al. 
2014).  The genome consists of two linked components, designated as UL (unique long) 
and US (unique short). The UL and US segments are each bracketed by inverted repeat 
sequences arranged as ab-UL-b’a’c’-US-ca (Figure 1.2) (Wadsworth, Jacob, and 
Roizman 1975; Hayward et al. 1975). Genomic isomerization occurs by recombination 
between the inverted repeats, leading to the formation of four isomers during DNA 
replication (Sheldrick and Berthelot 1975). The genome has a total of three origins of 
replication designated as OriS and OriL. Two copies of OriS are found in the c repeat 
region and OriL is located in the UL region of the genome (Weller et al. 1985; Stow 
1985). The significance of having multiple origins of replication is not fully understood. 
Mutants that have only one origin are capable of replicating in cell culture although they 
undergo frequent recombination events to create origin duplicates, indicating that there 
is significance for having multiple origins (Polvino-Bodnar, Orberg, and Schaffer 1987; 
Igarashi et al. 1993).  
The HSV-1 genome has at least 90 open reading frames and viral proteins are 
generally classified into three temporal kinetic classes; immediate early (IE, or α), early 
(E, or β), and late (L, or γ) (Honess and Roizman 1974; Pellett and Roizman 2013).  
5
a a’ ab b’ cc’UL US
OriL OriS OriS
Figure 1.2 HSV-1 Genome.  The HSV-1 genome is 152Kb and contains two
 unique seguments (UL and US). These segments are anked by repeat regions
 (a, b and c). The genome also has three orgins of replication, one copy of OriL 
 and two copies of OriS. This schemtic is not drawn to scale. 
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These proteins have been named by referring to their relative protein size to one 
another or their position along the viral genome. The two earlier naming approaches 
were based on the protein band size in an SDS-PAGE gel; Virion Polypeptide (VP) or 
Infected Cell protein (ICP) followed by a number corresponding to their size. Proteins 
were later named based on the position of the transcript in the genome, starting with the 
segment location (either UL or US) and then numbered from left to right.  
 
HSV-1 also encodes a number of noncoding transcripts that are mostly involved in 
establishing latency; most notable is the long-noncoding RNA Latency Associated 
Transcript (LATs) and at least 17 microRNAs predominately found in the OriS and OriL 
regions (Stevens et al. 1987; Spivack and Fraser 1987; Umbach et al. 2009) (Roizman, 
Knipe, and Whitley 2013).  
  
HSV-1 capsid  
The HSV-1 capsid is a 125 nm icosahedron with 162 capsomers, including 140 hexons, 
11 pentons and a portal. The major capsid proteins are VP5, VP26, VP23 and VP19C; 
additionally, a number of minor capsid proteins are also required for the processing and 
packaging of the viral genome into preformed capsids (Conway and Homa 2011). 
Furthermore, the capsid also contains a portal that is involved in taking up and releasing 
viral DNA. This portal is a ring composed of twelve UL6 protein monomers. Our group 
has identified that the leucine zipper region within UL6 and disulfide bond formation are 
both important for inter-subunit interactions and stable portal ring formation (Nellissery 
et al. 2007; Szczepaniak et al. 2011; Albright et al. 2011) .    
7
 Tegument 
The tegument is a layer of proteins between the nucleocapsid and the envelope.   This 
largely unstructured region contains at least 23 viral proteins and some cellular proteins 
and transcripts (Loret, Guay, and Lippé 2008; Xu, Che, and Li 2016; Dai and Zhou 
2018). The tegument proteins are involved in trafficking viral particles during entry and 
egress, viral gene expression and evading host defenses (Kelly et al. 2009). Some 
noteworthy proteins in the tegument that are involved in gene expression include: ICP4, 
the major viral transcription regulator and the transactivator protein VP16 (Yao and 
Courtney 1989; Loret, Guay, and Lippé 2008; Naldinho-Souto, Browne, and Minson 
2006). Furthermore, a few tegument proteins are involved in establishing a favorable 
cellular environment for HSV-1 infection; such as, the virion host shutoff  (VHS) protein 
that cleaves cellular mRNA and the ubiquitin viral ligase, ICP0, which counteracts 
intrinsic cellular responses to viral infection (Roizman, Knipe, and Whitley 2013; Everett 
2000; Strelow and Leib 1995). 
Envelope 
The outermost layer of the virion is a lipid bilayer envelope, which protects the virion 
and facilitates entry into the host cell. The envelop is composed of host cell derived 
lipids and at least 13 distinct virus encoded glycoproteins (Roizman, Knipe, and Whitley 
2013; Arii and Kawaguchi 2018). The lipid composition of the envelope is similar to the 
cytoplasmic membranes of the Golgi apparatus and is acquired during passage of the 
capsid from the nucleus to the Golgi complex (van Genderen et al. 1994; Johnson and 
Baines 2011). 
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1.3 HSV-1 pathogenesis and Life cycle overview 
HSV-1 has a biphasic life cycle that begins with a primary lytic infection in epithelial cells 
of the oral mucosa and is followed by a latent phase in the trigeminal ganglion. The 
most common clinical manifestation of HSV-1 is the presence of orolabial lesions, which 
are visible indicators that the virus is shedding. Direct contact between skin abrasions of 
an uninfected individual with these lesions or the saliva of an infected individual results 
in viral transmission. Viral shedding is the most robust during symptomatic infection; 
however, asymptomatic individuals are also shedding the virus and can transmit to 
others (Wilson and Mohr 2012; Basavarajappa et al. 2015). 
Entry of HSV-1 into the host cell involves interactions between at least five envelope 
glycoproteins and several cell surface targets. The initial step in the entry process 
requires attachment of virion glycoproteins gB and gC to heparin sulfate 
(glycosaminoglycan). Afterwards, the virion enters the cell by either fusion of the 
envelope with the plasma membrane or by endocytosis. The pathway of entry varies 
depending on cell type, although both mechanisms involve interaction of gD with one of 
the following cell surface targets; nectins, herpesvirus entry mediator (HVEM) or 3-O-
sulfated heparan sulfate (3-OS HS) (Herold et al. 1991; Spear, Eisenberg, and Cohen 
2000; Jogger, Montgomery, and Spear 2004; Arii and Kawaguchi 2018; Pellett and 
Roizman 2013). The interaction between gD and the aforementioned cell surface 
targets facilitate the formation of a fusion proteins complex, gB/gH/gL, which is involved 
in the actual fusion event (Eisenberg et al. 2012; Reske et al. 2007). Once the capsid 
enters the cytoplasm it is trafficked along microtubules by the dynein-dynactin motor 
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complex until it docks at a nuclear pore and ejects the viral DNA into the nucleoplasm 
(Morgan, Rose, and Mednis 1968; Sodeik, Ebersold, and Helenius 1997; Ojala et al. 
2000). 
The early stages after genome entry are critical for establishing a nuclear environment 
that promotes successful DNA replication and propagation of progeny. The virus 
encodes many of its own proteins but also depends on the host’s cellular machinery for 
many critical functions. For example, all viral gene transcription is dependent on RNA 
polymerase II and the expression of the five IE proteins (ICP0, ICP4, ICP22, ICP27 and 
ICP47) requires cellular transcription factors, Oct1 and HCF, in coordination with the 
viral transcription factor VP16 (Whitlow and Kristie 2009; Arvin, Campadelli-Fiume, 
Mocarski, Moore, Roizman, Whitley, Yamanishi, and Sandri-Goldin 2007; Alwine, 
Steinhart, and Hill 1974).  
The IE proteins are expressed before the onset of DNA replication and are involved in 
promoting an environment that is conducive for viral infection. ICP0 is highly involved in 
counteracting intrinsic cellular resistance to viral infection (reviewed in (Boutell and 
Everett 2013; Lanfranca, Mostafa, and Davido 2014)). Furthermore, IE protein ICP4 is 
the major viral transcription factor that promotes the transcription of most viral genes 
(Wagner and DeLuca 2013).  
HSV-1 encodes seven replication proteins that are expressed as early genes; a single-
stranded DNA (ssDNA) binding protein (ICP8), an origin binding protein (UL9), the 
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helicase-primase complex (UL5-UL8-UL52), and the polymerase and its processivity 
factor (UL30/UL42) (reviewed in (Weller and Coen 2012b)). Section 1.4 of this thesis 
will address the replication proteins in detail, and the mechanism of DNA replication will 
be covered in section 1.5.  After DNA replication is completed L protein expression 
commences, and the L proteins are mostly involved in capsid assembly and genome 
packaging. The initial product of HSV-1 replication is a longer than unit length 
concatemer, which is cleaved into genome length segments while concurrently 
packaged into viral capsids (reviewed in (Conway and Homa 2011)). The capsid then 
undergo a series of envelopment and de-envelopment steps through the nuclear 
membrane and Golgi apparatus until the virion is finally released out of the host cell 
(van Genderen et al. 1994; Mettenleiter, Klupp, and Granzow 2009).  
 Gene expression, DNA replication and viral DNA packaging all occur in large, globular 
membrane-less structures called replication compartments (Quinlan, Chen, and Knipe 
1984; Lamberti and Weller 1996; Phelan et al. 1997; de Bruyn Kops and Knipe 1988). 
These compartments are formed in a stepwise assembly process that involves 
interactions between DNA replication proteins, cellular proteins, the viral genome and 
the nuclear environment. The details of replication compartment formation will be 
covered in Section 1.6. The ICP8 protein is essential for the formation of replication 
compartments (de Bruyn Kops and Knipe 1988; Bush et al. 1991; McNamee, Taylor, 
and Knipe 2000). This thesis will explore the protein interactions of ICP8 with both itself 
and other viral replication proteins, to improve our understanding of replication 
compartment assembly.  
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1.4. HSV-1 DNA replication proteins 
HSV-1 is the most extensively studied member of the Herpesviridae family and is used 
as a model for understanding DNA replication in this family of viruses. This section 
introduces the seven-replication proteins. ICP8 is the central focus of this thesis; 
therefore, additional emphasis will be placed on ICP8s’ interactions with the other viral 
replication proteins.  
A. Single strand DNA binding protein, ICP8
Overview 
ICP8 is a 128-kDa globular zinc metalloprotein (Gupte, Olson, and Ruyechan 1991) that 
binds ssDNA in a non-sequence specific and cooperative manner (Ruyechan 1983; 
Mapelli et al. 2000). It is essential for HSV-1 infection and is involved in viral DNA 
synthesis (Conley et al. 1981; Challberg 1986; Weller et al. 1983; C. A. Wu et al. 1988). 
ICP8 is required for coupled leading and lagging strand DNA synthesis (Hernandez and 
Lehman 1990; Ruyechan and Weir 1984; Falkenberg, Lehman, and Elias 2000).  ICP8 
also exhibits helix destabilizing activity, strand annealing activity and can promote 
strand exchange (Boehmer and Lehman 1993a; Dutch and Lehman 1993; Mapelli et al. 
2000; Reuven and Weller 2005; Reuven et al. 2003). 
A multifunctional protein, ICP8 has been reported to functionally or physically interact 
with many viral proteins and at least 50 cellular proteins; its viral interaction partners 
include UL9, UL30/42, UL5/8/52, alkaline nuclease (UL12) and immediate early proteins 
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ICP4 and ICP27 (T. J. Taylor and Knipe 2004). However, the regions of ICP8 
responsible for these different functional interactions have not been identified.  
 
ICP8 structure 
The crystal structure of ICP8 was solved using a mutant of ICP8, ICP8Δ60Ccc, that has 
a C-terminal 60 residue deletion and two point mutations at C254S and C455S (Mapelli, 
Panjikar, and Tucker 2005). This mutant was selected because full length ICP8 is prone 
to aggregation and produces poor quality crystals (Mapelli and Tucker 1999). The 
ICP8Δ60Ccc mutant binds to ssDNA with similar affinity as wild type ICP8 but exhibits a 
complete loss of cooperativity (Mapelli et al. 2000). The crystals of ICP8Δ60Ccc 
diffracted to at least 3Å resolution, and Multi-wavelength Anomalous Dispersion (MAD) 
was used to solve the protein structure. ICP8 consists of a large N-terminal domain (9 –
1038) and a smaller helical C-terminal domain (1049–1129). The N-terminal domain is 
divided into several regions called the head, neck and shoulder. However, these regions 
cannot be separated because non-contiguous polypeptide chains form the protein’s 
tertiary structure. The C-terminal domain (1049 –1129) is mostly helical and is 
connected to the N-terminal domain by an 11 residue disordered linker (Mapelli, 
Panjikar, and Tucker 2005). The structure of the 60 C-terminal residues of ICP8 has not 
been solved; a bioinformatics analysis of this region has reveled a mostly disordered 
structure (Hoch and Schuyler, unpublished).  
 
The zinc-binding region of ICP8 contains four highly conserved residues (C499, C502, 
C510 and H512) that coordinate one zinc molecule per protein (Gupte, Olson, and 
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Ruyechan 1991). Mutations in residues C499 and C502 produce a non-functional 
protein that is incapable of complementation (Gao et al. 1988). However, a zinc 
depleted ICP8 molecule still retains DNA binding activity, which suggests a structural 
role for the zinc binding region (Gupte, Olson, and Ruyechan 1991). 
 ssDNA binding and cooperativity  
The DNA binding activity of ICP8 was first identified during a DNA-cellulose 
chromatography experiment of HSV-1 and HSV-2 infected cell extracts; these early 
experiments demonstrated a tighter binding affinity of ICP8 to single stranded DNA than 
to double stranded DNA (Bayliss, Marsden, and Hay 1975; Purifoy and Powell 1976; 
Powell and Purifoy 1976; C. K. Lee and Knipe 1985). Additional in vitro binding studies 
and electron microscopy analysis of ICP8 revealed that it binds cooperatively to DNA 
and can hold it in an extend configuration (Ruyechan 1983; Ruyechan and Weir 1984). 
The DNA binding footprint of ICP8 on ssDNA was estimated to be 10 -14 nucleotides 
(White and Boehmer 1999; Mapelli, Panjikar, and Tucker 2005; Mapelli and Tucker 
1999).        
Numerous attempts have been made to map the ssDNA-binding domain in ICP8. Initial 
studies based on mapping temperature sensitive mutants (ts13, ts18, and tsHA1) 
defective in DNA binding suggested the involvement of amino acid residues 348-450 
(Gao et al. 1988). Gao and Knipe later proposed a ssDNA binding region between 
amino acid residues 564-1110, based on characterization of several ICP8 mutant 
viruses with internal deletions or C-terminal truncations in the ICP8 gene (Gao and 
Knipe 1989).  A subsequent proteolytic analysis of ICP8 by Wang and Hall suggested a 
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DNA binding region exists between residues 300-849 (Y. S. Wang and Hall 1990). 
Furthermore, photoaffinity labeling of ICP8 with BrdU-oligonucleodies followed by 
proteolysis suggested an approximately similar ssDNA binding region between residues 
386-902 (White and Boehmer 1999).   
 
The studies mentioned above identified large regions in ICP8 that are potentially 
involved in DNA binding, although no specific residues in the protein have been 
assigned DNA binding function. However, after the crystal structure of ICP8 was solved, 
a modeling analysis of ssDNA in the neck region of ICP8 revealed several surface 
exposed aromatic and positively charged conserved residues (Tyr 543, Asn 551, Arg 
772, Lys 774, Arg 776, Tyr 988, Phe 998, and Asn1002) that were suggested to be 
involved in ssDNA binding (Mapelli, Panjikar, and Tucker 2005).  
 
The significance of the C-terminal region of ICP8 for cooperative binding was not initially 
evident; it was originally presumed to be involved in ssDNA binding directly (Gao and 
Knipe 1989; Leinbach and Heath 1988). However, Mapelli et al. demonstrated by a 
series of electrophoretic mobility shift assay (EMSA) experiments that the 60 C-terminal 
residues in ICP8 are responsible for cooperative binding, and that removal of these 
residues did not affect the intrinsic DNA binding ability of ICP8 (Mapelli et al. 2000). 
Furthermore, a prior study by Dudas at el. identified two cysteines at residues 254 and 
455 by fluorescein-5-maleimide modification that also seemed to affect cooperative 
binding of ICP8 (Dudas and Ruyechan 1998). However, these cysteine residues were 
later proven to have a minor impact on cooperativity (Mapelli et al. 2000). 
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 ICP8 filaments 
ICP8 assembles into several different types of filaments: it forms long magnesium-
dependent left-handed helical protein filaments in the absence of DNA (O'Donnell et al. 
1987) and single helical protein filaments when it assembles on ssDNA (Bortner et al. 
1993; Makhov, Boehmer, and Lehman 1996; Makhov and Griffith 2006). Furthermore, 
ICP8 can form oligomeric rings when it binds to short ssDNA fragments (Makhov, 
Boehmer, and Lehman 1996). ICP8 also form thicker helical nucleoprotein filaments 
during the intermediate steps of an annealing reaction between two complementary 
strands of ssDNA, these type of filaments are distinct from the protein only or ssDNA 
bound filaments (Makhov and Griffith 2006).   
ICP8’s filament forming properties are not typical to classic single strand DNA binding 
proteins such as E. coli SSB or bacteriophage T4 gene 32 proteins. Those DNA binding 
proteins form smooth bead-like coatings along ssDNA and do not assemble into protein 
filaments in the absence of ssDNA. Whereas, ICP8 assembles on ssDNA as single 
helical filaments, similar to recombinase proteins such as RecA, UvsX and Rad51 (Flory 
and Radding 1982; Yu and Egelman 1993; Benson, Stasiak, and West 1994). The 
resemblance of ICP8 behavior on ssDNA to known recombinases suggests that it might 
share similarities in function. ICP8 has been reported to have annealing activity and can 
catalyze strand transfer reactions with the HSV-1 alkaline nuclease, UL12, these two 
proteins are thought to form a two-subunit recombinase (Bortner et al. 1993; Reuven et 
al. 2003). Visualizing the steps of an ICP8 mediated annealing reaction with electron 
microscopy revealed that ICP8 first forms thin nucleoprotein filaments on each of the 
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complementary ssDNA. These strands then intertwine with each other in a double-helix 
arrangement to form thicker nucleoprotein filaments. These super-helices promote the 
annealing of the two complementary ssDNA and are resolved upon the completion of 
the reaction (Makhov and Griffith 2006).   
The nucleoprotein filaments of ICP8 described above are different from the protein only 
filaments that ICP8 can form in the absence of DNA. An analysis based on negative-
staining electron microscopy and 3D helical reconstruction concluded that DNA 
independent filaments are double protein helices that have an anti-parallel orientation to 
each other (Makhov et al. 2009). Furthermore, it was found that the pitch of these 
bipolar filaments is 250 Å, with approximately 6.2 dimers per turn (Makhov et al. 2009). 
ICP8 homologs BALF2 and ORF6, Epstein-Barr virus (EBV) and Kaposi’s sarcoma-
associated herpesvirus (KSHV) ssDNA binding proteins, respectively, also form DNA-
free helical protein filaments (Ozgur, Damania, and Griffith 2011; Mumtsidu, Makhov, 
and Konarev 2008). The biological relevance of DNA independent filaments of ICP8 is 
not understood. 
B. UL9, origin-binding protein
The origin binding protein UL9 is 851 amino acids long and is essential for HSV-1 DNA 
replication but is not required after DNA synthesis has initiated (Carmichael, Kosovsky, 
and Weller 1988; Blümel and Matz 1995). UL9 forms a dimer in solution and 
demonstrates several biochemical activities including helicase unwinding, nucleoside 
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triphosphatase (NTPase), non-specific ssDNA binding and sequence specific 
cooperative DNA binding at an origin of replication (Bruckner et al. 1991; Dodson and 
Lehman 1993; Elias, Gustafsson, and Hammarsten 1990; Fierer and Challberg 1992; 
Hazuda, Perry, and McClements 1992; H. M. Weir, Calder, and Stow 1989; Elias et al. 
1992). The helicase activity in UL9 resides in a domain defined by seven conserved 
helicase motifs in the N-terminus of the protein (between residues 1-534); additionally, a 
C-terminus truncation of UL9 has been reported to retain helicase activity (Abbotts and
Stow 1995; Martinez, Shao, and Weller 1992). The N-terminus of UL9 binds ssDNA 
non-specifically whereas the C-terminus contains a conserved sequence element 
between residues 756-760 that is responsible for origin specific binding (Murata and 
Dodson 1999; Olsson et al. 2009).  
 UL9 is a complex protein that appears to be unique to Alpha herpesviruses without any 
known homologues in Beta and Gamma herpesviruses. Further details of how UL9 
functions to unwind the origin of replication will be discussed further below, in the 
section that addresses a model for DNA replication.  
ICP8-UL9 interaction 
UL9 interacts directly with ICP8, forming a specific co-complex that functions in opening 
and activating the origin of replication (Boehmer and Lehman 1993b; He and Lehman 
2000; Makhov et al. 2003; Aslani, Olsson, and Elias 2002). The helicase and ATPase 
activities of UL9 are stimulated through its interaction with ICP8 via a 13-amino acid 
sequence (WPMMQGAVNFSTL) in the extreme carboxyl terminus of UL9 (Olsson et al. 
2009; Boehmer 1998; Fierer and Challberg 1992; Boehmer, Craigie, and Stow 1994). 
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However, the reciprocal binding site on ICP8 has not been mapped.  UL9 also has the 
ability to interact with other viral and cellular proteins, including UL42 and UL8 (Trego 
and Parris 2003; McLean et al. 1994).  
 
C. UL5/8/52 Helicase-primase complex 
 
The HSV-1 helicase-primase consists of the products of three essential genes (UL5, 
UL8 and UL52), which form a heterotrimeric complex that is necessary for viral DNA 
synthesis (Crute et al. 1989; Carmichael and Weller 1989; Goldstein and Weller 1988; 
Zhu and Weller 1992b). The UL5 protein is 882 amino acid residues and contains seven 
super-family 1 conserved helicase motifs that are essential for viral growth and helicase 
and ATPase activities (Gorbalenya and Koonin 1993; Zhu and Weller 1992a). The UL52 
protein is 1058 amino acid residues and contains both a primase characteristic DID 
motif that is necessary for catalytic activity and a putative zinc-binding domain 
associated with DNA binding (Klinedinst and Challberg 1994; Dracheva, Koonin, and 
Crute 1995; Y. Chen et al. 2007). The UL5 and UL52 proteins are intricately 
interdependent; a subcomplex of these two proteins demonstrates helicase, NTPase 
and primase activities, although neither of these subunits individually exhibits any 
helicase or primase activity on their own (Dodson et al. 1989; Dodson and Lehman 
1991; Calder and Stow 1990). The UL8 protein is 750 amino acid residues and has 
been reported to be involved in the nuclear localization of the helicase-primase complex 
and it modulates the enzymatic activity of UL5 and UL52 (Sherman, Gottlieb, and 
Challberg 1992; Barnard, Brown, and Stow 1997; Tenney et al. 1994). UL8 was 
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previously assumed to have no catalytic function of its own, until a recent study by 
Bermek et al. reported that UL8 can bind to ssDNA and promote annealing between 
complementary ssDNA to form a highly branched DNA duplex structure. Furthermore, 
UL8 was visualized by electron microscopy to form filaments in the absence of DNA. 
The UL8 filaments appear to be flat and are very different from the double helical ICP8 
filaments (Bermek, Weller, and Griffith 2017).  
ICP8-UL5/8/52 interaction 
ICP8 stimulates the helicase, primase and ATPase activities of the UL5/8/52 complex; 
stimulation of this complex by ICP8 is dependent on the presence of the UL8 subunit. 
The E. coli ssDNA-binding protein is unable to substitute for ICP8, suggesting that there 
is a specific interaction between ICP8 and the UL8 protein (Hamatake, Bifano, Hurlburt, 
and Tenney 1997a; Falkenberg, Elias, and Lehman 1998). 
D. UL30/42 DNA Polymerase Holoenzyme
The HSV-1 DNA polymerase holoenzyme is a heterodimer composed of two essential 
viral replication proteins; a 1235 amino acid catalytic subunit encoded by the UL30 gene 
and a 488 amino acid processivity subunit encoded by the UL42 gene (Gottlieb et al. 
1990; Marchetti, Smith, and Schaffer 1988; Parris et al. 1988). UL30 serves as the 
polymerase and contains conserved motifs that are shared among members of the α-
like DNA polymerase family. The crystal structure of UL30 revealed the typical thumb, 
palm and fingers domains shared among polymerases (Gibbs et al. 1988; Liu et al. 
2006). Additionally, UL30 has been reported to have proofreading ability as a result of 
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its 3’-5’ exonuclease activity and apurinic/apyrimidinic lyase activity (Hwang et al. 1997; 
Bogani and Boehmer 2008).  
 The auxiliary protein UL42 stimulates long DNA chain synthesis by increasing the 
affinity of UL30 to its substrate (Gottlieb and Challberg 1994). The crystal structure of 
UL42 revealed that one surface of UL42 interacts with UL30 while the other surface is 
lined with positively charged residues and is presumed to bind DNA (Zuccola et al. 
2000). UL42 binds DNA as a monomer with high affinity and uses electrostatic 
interactions to slide along DNA while simultaneously bound to UL30, therefore tethering 
the polymerase to the DNA template and increasing processivity (Randell and Coen 
2001; Randell and Coen 2004; Randell et al. 2005; Jiang et al. 2007).  
ICP8-UL30/42 interaction 
ICP8 has been reported to stimulate the polymerase activity of UL30; an in vivo assay 
using M13mp18 primed substrate demonstrated that stimulation by ICP8 occurs over a 
narrow range in concentration and that amounts of ICP8 in excess of this range were 
not stimulatory (Hernandez and Lehman 1990; Ruyechan and Weir 1984; O'Donnell et 
al. 1987). Furthermore, ICP8 has been reported to co-immunoprecipitate with UL42 (T. 
J. Taylor and Knipe 2004; Stengel and Kuchta 2011).
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1.5 Model for DNA replication  
 
 Our lab and other research groups have spent the last several decades attempting to 
decipher the details of the DNA replication process. Our team has focused on various 
pieces of this puzzle, including but not limited to, genetic analysis and biochemical 
properties of the replication proteins, the viral DNA structure, capsid formation, 
formation of replication compartments, HSV-1 recombination, involvement of cellular 
proteins and the host DNA damage response to infection. Progress has been made in 
our understanding of HSV-1 DNA replication although a complete picture is still lacking.  
  
 The initial product of HSV-1 replication is a longer than unit length concatemer, which is 
cleaved into genome length segments while concurrently packaged into viral capsids 
(Deiss and Frenkel 1986; Baines and Weller 2005). Earlier models proposed to explain 
the long concatemeric DNA, suggested that the linear genome circularized in the 
infected cell and replication proceeded as a rolling circle mechanism (Garber, Beverley, 
and Coen 1993; Deshmane et al. 1995; Pellett and Roizman 2013; Poffenberger and 
Roizman 1985).   
  
The circularization of the genome during lytic infection is still widely debated; moreover, 
this model may be overly simplified and does not provide an explanation for genomic 
inversions or the high frequency of recombination that can occur between co-infecting 
viral genomes (Schaffer, Tevethia, and Benyesh-Melnick 1974; Dutch, Bianchi, and 
Lehman 1995; Fu, Wang, and Zhang 2002). The viral genome is presumed to have 
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branched intermediates because extracted viral DNA from infected cells is unable to 
enter a pulsed-field gel (Zhang, Efstathiou, and Simmons 1994; Severini et al. 1994). 
Furthermore, electron microscopy studies have revealed numerous X- and Y- shaped 
intermediate structures in replicating DNA (Jacob and Roizman 1977; Severini, Scraba, 
and Tyrrell 1996). A conclusive model for HSV-1 DNA replication should incorporate the 
evidence stated above which points towards a recombination-mediated replication 
process. 
Initiation phase of DNA Replication 
Our current understanding of HSV-1 DNA replication broadly consists of two major 
phases, the initiation step and the elongation step. The initial step in DNA replication 
involves the recognition of either OriL or one of the two copies of OriS by a complex of 
UL9 and ICP8. This UL9- ICP8 complex undergoes a series of conformational changes, 
which result in the distortion and unwinding of the origin. The first step of this unwinding 
process involves the cooperative binding of two UL9 dimers to the UL9 origin specific 
binding sites (box I, II or III) leading to the distortion of the A/T rich region (Elias et al. 
1992; Makhov, Boehmer, and Lehman 1996; He and Lehman 2001). Then, in a second 
step, UL9 along with ICP8 in the presence of ATP promotes the formation of a hairpin in 
the origin (oriS*) (Aslani, Olsson, and Elias 2002; Macao, Olsson, and Elias 2004; 
Makhov et al. 2003). During this step UL9 undergoes major conformational changes 
that alters its DNA binding abilities form duplex origin specific to nonspecific ssDNA 
binding (Macao, Olsson, and Elias 2004; Olsson et al. 2009). ICP8 may also undergo a 
conformational change triggered by the exposure of ssDNA resulting in its release from 
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UL9 (Gustafsson et al. 1995).  The involvement of UL9 in the initiation step is critical for 
productive DNA replication, although UL9 is not required during the subsequent DNA 
elongation phase(Blümel and Matz 1995; Schildgen et al. 2005). It is important to note, 
that the initiation process has mostly been studied with in vitro models using artificial 
substrates and may not be representative of what is happening during infection. Other 
viral or cellular factors might be involved during the initiation step of origin unwinding.   
Elongation phase of DNA replication  
After the initial distortion of the origin by UL9 and ICP8, the helicase primase complex 
(UL5/8/52) is probably recruited to the origin via protein- protein interactions. UL9 has 
been reported to interact with the UL8 subunit of the helicase-primase complex 
(McLean et al., 1994). Additionally, ICP8 can also interact with the helicase-primase 
complex and can stimulate its activities (Hamatake, Bifano, Hurlburt, and Tenney 
1997a; Falkenberg, Elias, and Lehman 1998). At least two molecules of the UL5/8/52 
complex are required for successful primase activity: whereas, the helicase activity of 
this complex requires only one molecule of UL5/8/52 (Y. Chen et al. 2011). This 
complex may also function as a scaffold to recruit the polymerase complex (UL30/42) to 
the replication fork. Furthermore, the UL8 subunit has been reported to interact with the 
viral polymerase (Marsden et al. 1996). Moreover, the helicase- primase complex needs 
to be active in order to recruit the polymerase, suggesting that conformational changes 
that occur to the active complex or the presence of an RNA primer are important for 
recruiting the polymerase (Carrington-Lawrence and Weller 2003). Once present at the 
replication fork, the viral polymerase has the ability to catalyze coupled leading and 
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lagging strand DNA synthesis (Stengel and Kuchta 2011). While much progress has 
been made in understanding DNA replication, we have still not been able to reconstitute 
origin dependent DNA replication in an in vitro system. This fact suggests that perhaps 
important cellular or viral factors could also be involved in this process, or that we do not 
yet fully appreciate the stoichiometry of the proteins at the replication fork. Moreover, 
the highly branched structures observed in HSV-1 replication products and the isomeric 
nature of the genome strongly suggests that the mode of replication involves 
recombination events. Work from our laboratory has also demonstrated that the 
occurrence of single strand annealing is increased in the context of an HSV-1 infection 
(Schumacher et al. 2012).   
1.6 Replication Compartment Formation 
HSV-1 replication causes dramatic reorganization of the nucleus into large globular non 
membrane bond structures referred to as replication compartments (Quinlan, Chen, and 
Knipe 1984). These compartments function to concentrate and compartmentalize viral 
and cellular molecules that are crucial for viral gene expression, DNA replication and 
viral capsid formation (de Bruyn Kops and Knipe 1988; Lamberti and Weller 1996; 
Phelan et al. 1997).  ICP8 is essential for the formation of replication compartments and 
is considered to be the nucleating factor required for their formation (de Bruyn Kops and 
Knipe 1988; Bush et al. 1991; McNamee, Taylor, and Knipe 2000). The formation of 
replication compartment occurs through a series of protein scaffold intermediate 






















Figure 1.3 HSV-1 Replication Compartment formation. The stages of prereplicative 
site formation are described in detail in the accompaning text.  
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formation can be observed naturally during an infection, although this processes 
happens rapidly. Hence, to determine the protein content of PRS during the different 
stages of formation; the progression of infection is paused by either using mutant 
viruses that are null for essential DNA replication proteins or by administrating drugs 
that prevent viral DNA synthesis.  
 
The first detectable stage of PRS formation is a nucleoprotein complex containing ICP4 
and ICP27 that forms on the viral genome (Liptak, Uprichard, and Knipe 1996; Everett 
et al. 2004). After which Nuclear domain 10 (ND-10) like foci forms adjacent to ICP4 
nucleoprotein complexes (Everett et al. 2004; Everett and Murray 2005). The ND-10 foci 
are thought to be suppressive to viral gene expression and are targeted for disruption 
by the virally encoded ubiquitin ligase, ICP0 (Everett 2001). The disruption of ND-10 
marks the transition from stage I to stage II. Further progression into stage II requires 
oligomerization of ICP4 on viral DNA. Moreover, this stage is characterized by the 
appearance of ICP8 micro-foci adjacent to ICP4 and these ICP8 micro-foci appear to 
merge with the ICP4/ICP27 foci. Furthermore, UL9 and the Helicase-primase complex 
are also detected during this early stage(Livingston et al. 2008).  
 
The prereplicative sites will continue to mature into stage IIIa if the helicase-primase 
complex is active. Stage IIIa foci contain all of the same viral replication proteins that 
are present at the end of stage II (ICP8, UL9, UL5/8/52) although the foci in stage IIIa 
are larger in size. The following stage IIIb foci contain all seven viral replication proteins 
and the polymerase is recruited to these sites only if an active primase is present 
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(Burkham et al., 1998; Carrington-Lawrence and Weller, 2003). These PRS sites will 
then coalesce to form larger replication compartments (stage IV) that occupy most of 
the nucleus if the polymerase is active (Chang et al. 2011).   
 
1.7 Thesis Objectives:  
 
HSV-1 is the most widely studied human herpes viruses and is a model for 
understanding other members of the family. Although DNA replication has been studied 
extensively in HSV-1 for many decades, the basic mechanisms that mediate HSV-1 
replication are still poorly understood.  This thesis focuses on understanding some of 
the protein- protein interactions involving the ssDNA binding protein ICP8, that mediate 
the assembly of functional replication compartments.  
 
The HSV-1 virus reorganizes the cellular nucleus into replication compartments and 
ICP8 is essential for the formation of the earliest detectable replication compartments. 
The physical and functional properties of ICP8 that contribute to replication 
compartment formation are poorly understood. ICP8 has been known to be essential for 
productive HSV-1 infection since the early 1980s, although not a single protein 
interaction motif has been identified. ICP8 forms double helical filaments in the absence 
of DNA; the biological relevance of these types of filaments is not understood. We 
are interested in understanding ICP8 self-interactions involved in filament formation and 
its possible connection to replication compartment formation.  In this thesis I sought to 
identify protein interaction motifs in ICP8. I hypothesize that ICP8 interactions with 
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itself and other viral replication proteins are essential for the localization and 
assembly of a functional replisome and formation of replication compartments. 
Two aims were pursued to test this hypothesis.  
Aim 1. ICP8 filament formation is required for replication compartment formation.  
Aim 2. Identify potential protein interaction sites on ICP8 that are critical for 




Materials and Methods 
 
2.1 Cell culture and viruses 
 African green monkey kidney (Vero) cells were purchased from the American Type 
Culture Collection and maintained in Dulbecco’s modified Eagle’s medium (DMEM) 
(Invitrogen, Carlsbad, CA) supplemented with 5% fetal bovine serum (FBS) and 0.1% 
penicillin-streptomycin. The ICP8 complementing cell line S2 was generously provided 
by David Knipe (Harvard University, Boston, MA) (Gao and Knipe 1989). S2 cells were 
maintained in DMEM with 5% FBS, 0.1% penicillin-streptomycin and kept under G418 
selection (400 ug/ml). The HSV-1 strain KOS was used as the WT strain in all 
experiments. The ICP8 null virus, HD-2, which contains an in-frame lacZ insertion and a 
deletion in the UL29 gene, was generously provided by David Knipe (Harvard Medical 
School, Cambridge MA) (Gao and Knipe 1989).  
 
2.2 DNA constructs and mutagenesis 
The ICP8 expression vector, pSAK-ICP8, contains the full length ICP8 gene under 
control of the CMV promoter (Schumacher et al. 2012). ICP8 mutants were constructed 
in pSAK-ICP8 for mammalian expression and pFastBac1 for the construction of 
recombinant baculoviruses. The ICP8Δ60NLS mutant was constructed by PCR 
amplification of the ICP8 gene in pSAK-ICP8 with primers that resulted in the deletion of 
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the C-terminal 60 aa of ICP8 and the addition of the SV40 NLS. The resulting PCR 
product was cloned into pSAK that had been digested with HindIII and EcoR1. ICP8Δ60 
was introduced into pFastBac1 using a similar strategy, except no NLS was added. 
Alanine substitutions in conserved motifs FNF (1142-1144) and FW (843,844) were 
made in pSAK-ICP8 and pFastBAC1-ICP8 using	 the	QuikChange II XL Site-Directed 
Mutagenesis Kit (Agilent Technologies) according to the manufacturer’s suggested 
protocol. The FNF mutant (pSAK-ICP8 FNF) contains three alanine residues in place of 
FNF and the FW mutant (pSAK-ICP8 FW) contains two alanine residues in place of FW. 
A double mutant containing both FNF and FW mutants (pSAK-ICP8 FW-FNF) was 
constructed by adding the FW mutation to pSAK- ICP8 FNF and pFastBac1-ICP8 FNF 
using	the	QuikChange II XL Site-Directed Mutagenesis Kit.  
 
2.3 Protein purification 
Recombinant baculoviruses bearing WT and mutant versions of ICP8 were generated in 
the Bac-to Bac system (Invitrogen) as previously described (Grady, Bai, and Weller 
2014). Sf9 insect cells were infected with recombinant baculovirus bearing WT or 
mutant versions of ICP8 and harvested at ~48-50 hours post infection (hpi). Purification 
was carried out as previously described (Reuven et al. 2003).  Briefly, infected insect 
cell pellets were resuspended in lysis buffer, homogenized and cleared by centrifugation 
at 30,000 rpm in a Ti70 rotor for 40 min.  The supernatant was applied to a Hi-load 
16/10 SP-Sepharose anion-exchange column and eluted with a salt gradient. An 
additional purification step was performed during purification of the FW mutant due to 
the presence of a contaminating nuclease. After SP-Sepharose chromatography, ICP8 
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protein containing fractions were pooled and further purified on a Superose 6 size 
exclusion column. ICP8 mutant Q706A-F707A was purified similarly to ICP8-FW 
mutant.  Purified proteins were resolved by denaturing 8% SDS-PAGE and visualized 
by Coomassie blue staining. Fractions containing the highest purity were dialyzed 
against storage buffer (20 mM Hepes pH 7.6, 1 mM DTT, 0.1 mM EDTA, 100 mM NaCl 
and 5% glycerol) and stored at -80°C. The UL5-UL8-UL52 complex was expressed in 
insect cells co-infected with recombinant baculoviruses bearing UL5, His-tagged UL8, 
and UL52. The heterotrimeric complex was purified on a HIS-Select nickel affinity 
column (Sigma) as previously described (Y. Chen et al. 2005). 
 
2.4 Electron microscopy  
Purified protein samples at a concentration of 0.3 mg/mL were incubated in a buffer 
containing 20 mM Tris-HCl pH 7.5, 50 mM NaCl and 5 mM MgCl2 overnight at 4°C. 
Samples were diluted 1:10 in water, adsorbed on a formvar/carbon coated 300 mesh 
copper grids, negatively stained with 2% uranyl acetate and examined using TEM 
Hitachi H-7650 at an accelerating voltage of 80 kV. Images were taken at 
magnifications of 12,000X and 60,000X. For analysis of filament length, 0.15 mg/mL of 
WT ICP8 was incubated with an equal concentration of mutant protein or BSA and 
incubated overnight under filament forming conditions as described above. The lengths 





2.5 Immunofluorescence (IF) analysis  
IF analysis was performed as described previously (Livingston et al. 2008). Briefly, cells 
were grown on glass coverslips and washed with phosphate buffered saline (PBS), 
fixed with 4% paraformaldehyde, and permeabilized using 1% Triton X-100. Cells were 
blocked in 3% normal goat serum and incubated with the indicated antibodies: 
monoclonal mouse anti-ICP4 (1:200; US Biological), polyclonal rabbit anti-ICP8 clone 
367 [1:400; a gift from William Ruyechan (Shelton et al. 1994)]. Alexa Fluor secondary 
antibodies (1:200; Molecular Probes) were used with fluorophores excitable at a 
wavelength of 488 or 594 nm. All images were taken using a Zeiss LSM 510 Meta 
confocal microscope and a Zeiss 63X objective lens (numerical aperture, 1.4). Images 
were processed and arranged using Adobe Photoshop CS3 and Illustrator CS3. 
 
2.6 Transient complementation assays 
Vero cells were grown in a 35 mm dish to 70% confluence and transfected with 1 µg of 
plasmid using Lipofectamine Plus reagent (Invitrogen) according to the manufacturer’s 
suggested protocol. At 24 hours post transfection, cells were infected with HD-2 at an 
MOI of 3 pfu/cell for 1 h at 37°C. After an adsorption period of one hour, cells were 
washed twice with PBS and media was replaced. At 24 hpi cells and growth media were 
collected and subjected to three cycles of freezing and thawing. Viral yields were 
determined by titration on S2 complementing cells. To test for replication compartment 
formation, cells were grown on coverslips to 70% confluence and transfected with 250 
ng of the indicated plasmid and 750 ng of empty vector (as carrier DNA). At 16 hours 
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post transfection cells were infected with HD-2 (MOI = 20), and at 6 hpi cells were fixed 
and stained for IF analysis.  
2.7 Plaque reduction assay 
Infectious DNA was prepared as previously described (S. Smith et al. 2014). Vero cells 
were grown in a 60 mm dish to 70% confluence and transfected with 25 ng of infectious 
WT KOS DNA, along with 100 ng of plasmid expressing WT or mutant versions of ICP8 
(FNF, FW or FW-FNF); the ICP8 plasmid was in 80-fold molar excess to infectious 
DNA. In addition, 1.4 µg of carrier DNA (pUC19 empty vector) was included in the 
transfection mixture. At 24 hours post transfection, cells were washed with PBS and 
incubated for 4 days. Plaques were counted, and data was presented as percentage of 
plaque reduction compared to WT. 
 
2.8 ssDNA binding assay  
Fluorescently labeled 50nt ssDNA substrate (F50nt5’cy3): 
TGCGGATGGCTTAGAGCTTAATTGCTGAATCTGGTGCTGTAGCTCAACAT) was 
purchased from Integrated DNA Technologies. Reaction mixtures (10 ul) containing 20 
mM Tris-HCl (pH 7.5), 4% glycerol, 0.1 mg/ml bovine serum albumin (BSA), 0.5 mM 
DTT, 5 mM MgCl2, and 100 nM fluorescently labeled substrate were incubated with the 
indicated amount of WT or mutated ICP8 protein for 30 min at room temperature. 
Reactions were stopped by addition of 2 ul of 6x loading buffer (40% sucrose) and 
loaded onto 5% nondenaturing PAGE. Fluorescent signal was visualized using a Bio 
Rad Chemi-Doc MP imaging system. 
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2.9 Transfection assay 
Vero cells were grown on a glass coverslip in a 35 mm dish to 70% confluence and 
transfected with 250 ng of the indicated ICP8 WT or mutant plasmid and 250 ng of each 
of the following plasmids UL8 (pCM-UL8), UL5 (pCM-UL5b), UL52 (pCMV-UL52) 
(provided as a gift from Regina Heilbronn (Heilbronn and Hausen 1989). Cells were 
transfected with Lipofectamine PLUS (Invitrogen) according to the manufacturer's 
suggested protocol. Twenty hours after transfection cells were fixed and stained for IF 
analysis.  
2.10 Surface plasmon resonance (SPR) 
 Protein-protein interactions were studied in real time using the Biacore T200 optical 
biosensor (GE Healthcare). Purified WT or mutant ICP8 proteins (FNF, FW, FW-FNF 
and Δ60) were covalently immobilized by amine coupling through EDC/NHS on a CM5 
sensor chip. UL5/8/52 analyte in HSB buffer (10 mM HEPES pH 7.4, 3 mM EDTA, 150 
mM NaCl and 0.05% surfactant P20) was injected over the sensor surface at a flow rate 
of 30 µL/min for 180 sec (on rate) then followed by HSB buffer at the same flow rate for 
another 180 sec (off rate). The sensor chip was regenerated between injections by 
passing 10 mM NaOH at a flow rate of 50 µL/min for 120 sec. Purified bovine serum 
albumin (BSA; Sigma) was used as a negative control. The data was analyzed using 
the Biacore T200 evaluation software, and was fitted onto the 1:1 Langmuir binding 
model. 
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2.11 Prediction of protein interaction sites 
To identify potential protein interaction sites on ICP8 we first identified conserved ICP8 
residues by a sequence alignment of ICP8 orthologues from representatives of three 
sub families of Herpesviridae (Alphaherpes, Betaherpes, and Gammaherpes virus) 
using the t-coffee multiple sequence alignment program (Notredame, Higgins, and 
Heringa 2000). Secondly, we determined the distance of a conserved residue from the 
surface by using Pymol (reference for Pymol). Residues within 10 Å² to the surface and 
in close proximity to other conserved residues were categorized as potential protein 
interaction sites. Alanine substitution mutations were then constructed in the ICP8 
amino acid residues that were proposed to be protein interaction sites as described in 
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HSV dramatically reorganizes the infected cell nucleus leading to the formation of 
prereplicative sites (PRS) and replication compartments (RC). This process is driven by 
the essential viral ssDNA binding protein, ICP8, which can form double helical filaments 
in the absence of DNA. In this paper we show that two conserved regions FNF (F1142, 
N1143, and F1144), and FW (F843 and W844) are essential for ICP8 self-interactions, 
and we propose that the FNF motif docks into the FW region during filament formation. 
Mammalian expression plasmids bearing mutations in these motifs (FNF and FW) were 
unable to complement an ICP8 null mutant for growth and replication compartment 
formation. Furthermore, FNF and FW mutants were able to inhibit wild type (WT) virus 
plaque formation and filament formation; whereas, a double mutant (FNF-FW) was not. 
These results suggest that single mutant proteins are incorporated into non-productive 
ICP8 filaments, while the double mutant is unable to interact with WT ICP8 and does 
not interfere with WT growth. Cells transfected with WT ICP8 and helicase/primase 
(H/P) complex exhibited punctate nuclear structures that resemble PRS; however, the 
FNF and FW mutants failed to do so. Taken together these results suggest that the FNF 
and FW motifs are required for ICP8 self-interactions and that these interactions may be 
important for the formation of PRS and RC. We propose that filaments or other higher 
order structures of ICP8 may provide a scaffold onto which other proteins can be 
recruited to form PRS and RC. 
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INTRODUCTION: 
Herpes Simplex Virus Type 1 (HSV-1) is a double stranded DNA virus that replicates in 
the nucleus of an infected cell in large globular domains called replication compartments 
(Quinlan, Chen, and Knipe 1984). These compartments are non-membrane bound 
structures in the nucleus that serve to concentrate and compartmentalize viral and 
cellular molecules that are required for gene expression, DNA replication and 
encapsidation (de Bruyn Kops and Knipe 1988; Lamberti and Weller 1996; Phelan et al. 
1997). HSV-1 encodes seven essential replication proteins required for origin-
dependent DNA replication: a single strand DNA binding protein (ICP8), an origin 
binding protein (UL9), the helicase-primase complex (UL5/8/52) and the polymerase 
complex (UL30/42) (reviewed in (Weller and Coen 2012a)). All seven replication 
proteins as well as several cellular proteins localize to replication compartments in HSV-
infected cells (Olivo, Nelson, and Challberg 1989; Lukonis and Weller 1996; Quinlan, 
Chen, and Knipe 1984; Wilcock and Lane 1991; Wilkinson and Weller 2004; T. J. Taylor 
and Knipe 2004; Mohni et al. 2010; Mohni et al. 2011).       
Replication compartment formation in HSV-infected cells occurs via an ordered 
sequence of events starting with the formation of ICP4/27 nucleoprotein complexes on 
viral genomes (Liptak, Uprichard, and Knipe 1996; Everett et al. 2004). The first ICP8 
containing structures are punctate foci called prereplicative sites (PRS) that also contain 
the helicase/primase complex (UL5/8/52) and the origin binding protein, UL9 (Liptak, 
Uprichard, and Knipe 1996; Lukonis, Burkham, and Weller 1997). UL30 and UL42 are 
recruited to PRS (Carrington-Lawrence and Weller 2003), and when replication is 
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allowed to proceed, they coalesce with each other and with ICP4/27 foci to form mature 
replication compartments (T. J. Taylor et al. 2003; Chang et al. 2011). The absence of 
PRS in cells infected with an ICP8 null mutant virus has been taken as evidence that 
ICP8 is the nucleating factor required for their formation (de Bruyn Kops and Knipe 
1988; Bush et al. 1991; McNamee, Taylor, and Knipe 2000). During the formation of 
PRS and RC, ICP8 is known to undergo conformational changes (Uprichard and Knipe 
2003a); however, it is not clear how these changes contribute to PRS and RC 
formation.  
 
ICP8 is a 128-kDa zinc metalloprotein that binds ssDNA cooperatively and forms thin 
nucleoprotein filaments on ssDNA (Makhov and Griffith 2006; Tolun et al. 2013) and 
double helical filaments in the absence of DNA (O'Donnell et al. 1987; Makhov et al. 
2009). The 60 C-terminal residues of ICP8 are required for both filament formation and 
cooperative binding to ssDNA (Mumtsidu, Makhov, and Konarev 2008; Mapelli et al. 
2000). In 2005, the crystal structure of ICP8 lacking the C-terminal 60 aa residues was 
reported, revealing an N-terminal domain (residues 9-1038) that was described as 
containing head, neck and shoulder regions (Mapelli, Panjikar, and Tucker 2005). 
Based on the ICP8 structure, Mapelli et al. predicted putative ssDNA binding residues 
as well as residues that may be important for protein-protein interactions. For instance, 
they suggested that conserved residues, F827, F843, W844, L857 and I865 within the 
head region form a hydrophobic pocket that could interact with another protein (Mapelli, 
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 Figure 3.1. ICP8 protein structure. (A) Ribbon diagram of ICP8 colored according
to subdomain: the head, neck and shoulder subdomains are colored red, yellow, 
and blue, respectively; the C-terminal domain is colored purple. The green spheres 
show the alpha-carbon of the FW residues within the head subdomain. The 60
C-terminal residues of ICP8 are not represented in the structure. (PDB ID 1URJ)
(B) Schematic of ICP8 protein depicting the locations of the FW motif and the FNF
motif. A double and a triple alanine substitution in F843 W844 (FW) and
F1142 N1143 F1144 (FNF), respectively, were generated as described in
Materials and Methods (C) WT and mutant versions (FNF, FW, FW-FNF and Δ60)
of ICP8 were expressed and purified from Sf9 insect cells infected with recombinant
baculoviruses and purified as described in Materials and Methods. Purified proteins










In this study, we identified two conserved motifs involved in filament formation, one 
within the C-terminal 60 amino acids (1142-1144 FNF) and the other within the 
hydrophobic head region (F843 and W844) that had been predicted to participate in 
protein interactions (Mapelli, Panjikar, and Tucker 2005). Mutant proteins containing 
alanine substitutions within these motifs failed to form filaments in solution and were 
unable to complement an ICP8 null mutant for viral growth and replication compartment 
formation. Furthermore, these mutants were unable to form prereplicative site-like foci in 
transfection-based assays. We propose that filaments of ICP8 may form a scaffold onto 
which other viral and cellular proteins can be recruited to assemble PRS and RCs. 
RESULTS 
The FNF and FW motifs of ICP8 are required for filament formation  
The HSV ssDNA binding protein, ICP8, has been reported to form double helical protein 
filaments in vitro in the absence of DNA (O'Donnell et al. 1987; Makhov, Taylor, and 
Griffith 2004; Makhov et al. 2009). ICP8 homologs BALF2 from Epstein-Barr virus (EBV) 
and ORF6 from Kaposi’s sarcoma-associated herpesvirus (KSHV) also form double 
helical protein filaments (Ozgur, Damania, and Griffith 2011; Mumtsidu, Makhov, and 
Konarev 2008), suggesting that filament formation is a common property of herpesvirus 
ssDNA binding proteins. Removal of the 60 C-terminal amino acids from ICP8, BALF 
and ORF6 has been reported to eliminate filament formation and to reduce cooperative 
binding to ssDNA (Mumtsidu, Makhov, and Konarev 2008; Ozgur and Griffith 2014; 
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Mapelli et al. 2000). These observations suggest that the 60 C-terminal residues of 
ICP8 and its homologs contain residues important for protein-protein interactions that 
mediate filament formation and cooperative binding (Mapelli et al. 2000; Mapelli, 
Panjikar, and Tucker 2005; Mumtsidu, Makhov, and Konarev 2008; Ozgur and Griffith 
2014). ICP8 has emerged as the nucleating factor for replication compartment formation 
(de Bruyn Kops and Knipe 1988; Bush et al. 1991; McNamee, Taylor, and Knipe 2000), 
and we are interested in the relationship between filament formation in vitro and 
replication compartment formation in HSV-infected cells.  
Sequence alignments of ICP8 homologs from the alpha Herpesviridae subfamily 
revealed a conserved region within the C-terminal 60aa that was predicted to be 
involved in filament formation (Mapelli, Panjikar, and Tucker 2005). Within this region, 
the FNF motif (F1142, N1443 and F1144) was predicted to play a role in ICP8-ICP8 
interactions (Mapelli, Panjikar, and Tucker 2005). Furthermore, a mutation in the FNF 
region (F1144C) was previously reported to be unable to complement the growth of an 
ICP8 null virus or to localize to replication compartments (T. J. Taylor and Knipe 2003). 
The FNF motif was predicted to dock into a conserved hydrophobic region (F827, F843, 
W844, L857, and I865) in the head region of a neighboring ICP8 molecule (Mapelli, 
Panjikar, and Tucker 2005) (Figure 3.1A, B); however, these predictions have never 
been directly tested nor has the F114C mutation been studied for its ability to form 
filaments in vitro. In order to test these predictions, we introduced a triple alanine 
mutation in the FNF motif and a double alanine mutation in the FW motif (residues F843 
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and W844) (figure 3.1 B). We also reconstructed the previously engineered 60aa C-
terminal deletion for comparison with the alanine substitution mutations.   
WT and mutant proteins were purified from insect cells infected with recombinant 
baculoviruses (Figure 3.1C) and tested for their ability to form filaments in vitro. ICP8 
proteins were incubated under conditions previously shown to promote filament 
formation and subjected to analysis by electron microscopy as described in Materials 
and Methods. As anticipated, WT ICP8 was able to form a double helical filament 
(Figure 3.2A, B), while ICP8Δ60 was unable to do so (Figure 3.2F). Neither the FNF nor 
FW mutant proteins were able to form filaments under these conditions; instead, these 
proteins formed small clusters consistent with monomers or dimers (Figure 3.2C, D, and 
E). These observations suggest that intact FNF and FW motifs in ICP8 may be required 
for self-interactions between ICP8 molecules that lead to filament formation.  
ICP8 mutants that fail to form filaments are unable to complement the growth of 
an ICP8-null virus  
In order to test whether mutants that fail to form filaments retain the ability to 
complement the growth of an ICP8 null mutant virus, we introduced each of the mutant 
constructs into a mammalian expression vector under the control of the HCMV 
promoter. For ICP8∆60, which lacks an NLS, an SV40 NLS was added to ensure that 
ICP8∆60 localizes to the nucleus (Gao and Knipe 1992b; Gao and Knipe 1993). The 
ability of WT and mutant versions of ICP8 to complement the growth of an ICP8 null  
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Figure 3.2. Filament formation for wild type and mutant versions of ICP8 as 
visualized by electron microscopy. (A) and (B) ICP8 WT formed double helical 
filaments after overnight incubation at a concentration of 0.15mg/mL at 4oC in a 
5 mM MgCl2 containing buffer. Mutant ICP8 FNF (C), FW (D) FW-FNF (E), and
ICP8Δ60 (F) were unable to form filaments. All samples were negatively stained
with 2% uranyl acetate and visualized by electron microscopy at an accelerating 
voltage of 80 kV. Scale bar represents 100 nm (60,000 X)






















virus (HD-2) (Gao and Knipe 1989) was measured by transfecting Vero cells with WT or 
mutant versions of the ICP8 expression plasmids followed by infection with HD-2. 
Progeny virus was harvested 24 hours post infection, and viral yields were determined 
by titration on an ICP8 complementing cell line (S2) (Gao and Knipe 1989). None of the 
mutants were able to complement HD-2, and viral yields were comparable to cells 
transfected with an empty vector (Table 3.1). We conclude that the ICP8 mutants that 
fail to form filaments in vitro are also defective for viral growth.  
 
FW and FNF exhibit a trans-dominant phenotype. 
If, as we predict, the FNF motif docks into the hydrophobic head region of a neighboring 
ICP8 molecule, the FNF and FW motif mutants would be expected to exert a trans-
dominant inhibitory effect on ICP8 filament formation when co-expressed with WT ICP8. 
We predict that a mixture of mutant and WT ICP8 would generate a heterogeneous 
population of dimeric or higher order structures that could prevent ICP8 filament 
extension and inhibit infection. In the experiment shown in Figure 3.3A, Vero cells were 
transfected with mutant or WT versions of ICP8 along with infectious DNA isolated from 
cells infected with WT HSV-1 (KOS). The FNF and FW mutants displayed a reduction in 
plaque formation by almost 60% and 50% respectively. According to this scenario, we 
also predict that a double mutant bearing mutations in both the FNF and FW motifs 
would be unable to form mixed oligomers with WT ICP8. To test this hypothesis we 
constructed an ICP8 mutant containing both FW and FNF mutations. FW-FNF was 
tested for trans-dominance as described above. In contrast to the single mutants, the 





Table 1. Mutants that disrupt ICP8 filament formation fail to complement the 
growth of HD-2 virus 
 
 


















ICP8 100 0 
FW -0.1 0.13 
FNF 0.6 0.34 
FW-FNF 0.02 0.20 
Δ60 -0.2 0.11 
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Figure 3.3. FNF and FW mutants exhibit a transdominant phenotype. 
(A) A plaque reduction assay was conducted by transfecting Vero cells with
100 ng of plasmid expressing ICP8 WT or mutant versions of ICP8 (FNF, FW
or FW-FNF) and 25 ng of infectious KOS DNA. At 4 days post transfection,
plaques were counted. (B) Purified ICP8 protein was incubated with FNF, FW,
FW-FNF or BSA at equal concentrations (0.15 mg/mL) and incubated over
night at 4oC in a buffer containing 5 mM MgCl2. Electron microscopy was used
to image the samples, and the length of filaments in a100  µm2 area on the
grid were counted using Image J software analysis. Filament lengths were 
categorized as either < 200 nm, 200-400 nm, or  > 400 nm. The height of each
colored block signifies the number of filaments in that catergory.  
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that FNF and FW are trans-dominant inhibitors of infection, possibly as a result of their 
non-productive incorporation into ICP8 filaments.  The double mutant does not inhibit 
the growth of WT virus presumably because it lacks the ability to form ICP8-ICP8 
interactions and is therefore not able to incorporate into a growing ICP8 filament.  
To test whether the presence of mutant proteins could affect the length of ICP8 
filaments formed in vitro, a mixture of WT and mutant proteins in a 1:1 ratio were 
examined for filament formation. In order to include the double mutant protein in this 
analysis, FW-FNF was also introduced into a recombinant baculovirus, and purified 
protein was obtained from infected insect cells (Figure 3.1C). Like the single mutants, 
the double mutant is also incapable of filament formation (Figure 3.2). Samples were 
visualized by electron microscopy, and the lengths of filaments were measured using 
ImageJ software analysis (Figure 3.3B). The limiting size for observing a filament is 50 
nm; therefore, filaments over this size were counted and grouped into three categories: 
below 200 nm, between 200-400 nm or above 400 nm in length. The mixture of WT and 
FW-FNF mutant proteins exhibited a similar distribution of filaments in all three 
categories; however, FNF exhibited few filaments above 400 nm and a higher number 
of smaller structures. In the mixture containing WT and FW protein, however, very few 
structures were observed, indicating that the presence of this mutant protein was even 
more deleterious to WT filament formation than the FNF mutant. It will be of interest to 
determine why FW has an even more dramatic effect on mixed filament formation; 
however, at this point we can conclude that both mutants interfere with filament 
formation of WT ICP8 in vitro and on productive infection in Vero cells. The observation 
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that the double mutant alleviated the trans-dominant phenotype of the single motif 
mutants is consistent with the notion that the FNF motif docks at the FW region. 
 
Mutant proteins retain ability to bind ss DNA with reduced cooperativity 
The loss of filament formation may represent disruption of interaction domains 
responsible for ICP8-ICP8 interactions or destabilization of mutant proteins. To rule out 
global misfolding, we tested whether these mutants can still bind to ssDNA using an 
electrophoretic mobility shift assay (EMSA). In this assay, WT or mutant ICP8 proteins 
were incubated with a Cy3-labeled 50 nt oligomer, and the reaction products were 
resolved by 5% nondenaturing PAGE. Figure 3.4 shows that the WT and mutant 
proteins all bind to ssDNA in a concentration-dependent fashion; however, differences 
in the shift patterns were observed. WT ICP8 exhibited two predominant shifted bands, 
the slower of which may represent the ability of the WT protein to bind cooperatively to 
the 50 nt oligomer. All mutant proteins were able to shift ssDNA; however, none of the 
nucleoprotein complexes corresponded to the slowest species seen in the WT ICP8 
samples. These results suggest that as reported previously for ICP8∆60 (Mapelli et al. 
2000), FNF, FW and FW-FNF mutant proteins have lost their ability to bind 
cooperatively to ssDNA; however, the ability of all mutants to bind ssDNA indicates that 
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Figure 3.4. ICP8 mutants FNF, FW, FW-FNF and Δ60 retain the ability to
interact with ssDNA albeit with reduced cooperativity. ICP8 WT or Mutants
(FNF, FW, FW-FNF and Δ60) were incubated at concentrations of either 100 nM 
and 200 nM with 100 nM of 5′ fluorescein-labeled 50 nt length ssDNA substrate
for 30 min and the complexes were separated on 5% nondenaturing polyacrylamide 
gels. WT and mutants were able to bind DNA, although there was a difference in 
size of nucleoprotein complexes formed. ICP8 WT forms a supershifted complex 
that is absent in the mutants, suggesting a lack of cooperative binding in the mutants.
The signal was detected using Bio Rad Chemi-Doc MP imaging system.
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ICP8 mutants defective in filament formation are unable to generate replication 
compartments and PRS-like foci.  
As described in the introduction, ICP8 is required for the formation of replication 
compartments (de Bruyn Kops and Knipe 1988). To test whether ICP8 mutants that fail 
to form filaments in vitro are able to complement an ICP8 null mutant virus for the 
formation of replication compartments, Vero cells were transfected with either WT or  
mutant versions of ICP8 followed by infection HD-2 (MOI=20 for 6 hours). The 
immediate early protein ICP4 was used as a marker for infection, and transfected cells 
were identified based on ICP8 staining. Only cells that express ICP8 and ICP4 were 
analyzed. WT ICP8 was able to complement HD-2 for replication compartment 
formation (Figure 3.5A-C); however, none of the four mutants tested were able to do so 
(Figure 3.5D-O).  
Replication compartment formation occurs via an ordered sequence of events, and 
ICP8, helicase-primase and UL9 are present in the earliest detectable pre-replicative 
sites (PRS) (Kops and Knipe 1988; Liptak, Uprichard, and Knipe 1996; Lukonis, 
Burkham, and Weller 1997; Livingston et al. 2008). During the course of HSV infection, 
PRS foci grow and coalesce into replication compartments. A transfection-based assay 
has been developed that mimics PRS formation (Liptak, Uprichard, and Knipe 1996; 
Lukonis and Weller 1997). In cells transfected with ICP8 alone, a diffuse pattern is 
observed throughout the nucleus; however, in cells transfected with ICP8 plus the three 
subunits of the helicase/primase (UL5, UL8, UL52) punctate foci are observed that 
resemble PRS and have been called PRS-like foci (Lukonis and Weller 1997; Liptak, 
Uprichard, and Knipe 1996; Wilkinson and Weller 2004). We next asked whether ICP8  
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Figure 3.5. ICP8 mutants FNF, FW, FW-FNF and ICP8Δ60NLS do not form 
pre-replicative like structures.Vero cells were transfected with plasmids expressing 
(A and F) ICP8 WT, (B and G) FNF, (C and H) FW, (D and I) FW-FNF or (E and J)
ICP8Δ60NLS. In panels F-J plasmids expressing UL5, UL8 and UL52 were added. 
At 20 hours post transfection, cells were fixed and stained with a primary ICP8 
antibody and a secondary Alexa Fluor 488 antibody. Images were taken with Zeiss 
LSM 510 confocal microscope.
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Figure 3.6. ICP8 mutants are unable to complement HD-2 for replication 
compartment formation.Vero cells were transfected with (A) ICP8 WT or
mutants (B) FNF, (C) FW, (D) FW-FNF and ICP8Δ60NLS. At 16 hours
post-transfection cells were infected with an ICP8 null virus (MOI=20). 6 hours
post-infection cells were fixed and stained for ICP8 and ICP4 with secondary 
Alexa Fluor 488 and 594 antibodies, respectively.  Cells that were both
transfected and infected were selected for analysis, the viral immediate early
protein ICP4 was used as a marker for infection. Images were taken with Zeiss
LSM 510 confocal microscope.
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mutants that fail to form filaments in vitro are able to form PRS-like foci in transfected 
cells. Consistent with previous results, Vero cells transfected with WT or mutant 
versions of ICP8 displayed diffuse nuclear staining (Figure 3.6 panels A-E); however, in 
cells co-transfected with WT or mutant versions of ICP8 and helicase-primase, only 
ICP8 WT was capable of forming PRS-like structures (Figure 3.6F). The four ICP8 
mutants tested exhibited a diffuse distribution even in the presence of the helicase- 
primase complex (Figure 3.5 G-J). Taken together these experiments suggest that the 
ability to form filaments in vitro correlates with the formation of PRS-like foci and 
replication compartments.  
 
HSV-1 helicase primase complex (UL5/8/52) interacts with ICP8 mutants  
The ability of PRS-like foci to form in cells transfected with four viral proteins may reflect 
the fact that ICP8 can interact directly with the helicase-primase holoenzyme 
(Hamatake, Bifano, Hurlburt, and Tenney 1997b; Falkenberg, Elias, and Lehman 1998). 
The inability of mutant ICP8 to form PRS-like foci and RCs might suggest that mutant 
ICP8 proteins do not interact with the helicase-primase, To test this hypothesis we used 
surface plasmon resonance to measure binding of purified WT or mutant (FNF, FW, and 
FW-FNF) ICP8 protein to helicase primase. WT and mutant ICP8 proteins were 
immobilized on a biosensor chip, and UL5/8/52 was injected over the chip at various 
concentrations (25, 50, 100, 200, 400 nm). Figure 3.7 shows that WT and mutant forms 
of ICP8 both could interact with UL5/8/52. A negative control, BSA exhibited no binding 
(data not shown). The binding data were analyzed at various concentrations of 
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Figure 3.7.  Helicase-primase complex (UL5/8/52) interacts with wild type and 
FNF, FW, and FW-FNF mutant protein. SPR sensorgrams of increasing
concentrations of UL5/8/52 (25, 50, 100, 200, 400 nM) were performed using a 
BiacoreT200 at room temperature. The colored lines represent the binding of the 
analyte (UL5/8/52) at different concentrations over the specified ligand. The black
lines represents the data fitted using1:1 langmuir model,which was used to calculate 
the kinetic parameters of the reactions as summarized under each of the sensogram.  
binding parameters is shown under each sensogram (Figure 3.7). ICP8 WT and FW 
mutant interact with UL5/8/52 with comparable affinities with dissociation constants (KD) 
of 7.6 x 10-8 M and 9.9 x 10 -8 M, respectively. FNF and FW-FNF displayed slightly 
weaker binding affinities to helicase-primase, (KD = 1.8 x 10-7 M and 1.2 x 10-7 M, 
respectively). The fact that all three mutants bind helicase-primase with 
comparableaffinities indicates that the inability of these mutant proteins to form PRS 
and RCs is not due to loss of interaction with helicase-primase.  
DISCUSSION 
In this chapter, we report that two motifs in the ICP8 protein, FNF motif 1142-1144 in 
the C-terminus and the FW motif at residues 843 and 844 in the so-called hydrophobic 
head region, are important for filament formation and for progression of HSV infection. 
Recombinant mutant proteins bearing alanine substitutions in the FNF and FW motifs 
are unable to assemble into filaments in vitro. In addition, the FNF and FW mutants 
exert a dominant negative inhibitory effect on viral growth and on the ability of WT ICP8 
to form filaments in vitro. On the other hand a double mutant bearing both the FNF and 
FW mutations had no effect on WT growth or filament formation. These results suggest 
that the single mutants are capable of creating non-productive oligomers that interfere 
with the ability of WT ICP8 to form filaments; whereas, the double mutant lacks the 
ability to form ICP8-ICP8 interactions and was therefore not able to incorporate into a 
growing WT ICP8 filament. This result supports our hypothesis that the FNF motif is 
able to dock into the hydrophobic head region containing the FW motif. Mutants that fail 
to form filaments in vitro also fail to complement the growth of an ICP8 null virus or to 
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form PRS-like and replication compartments. ICP8 mutants that fail to form PRS-like 
structures can still interact with the helicase-primase complex, suggesting that the 
failure to form PRS is not due to the inability of mutant ICP8 protein to interact with 
helicase/primase. Taken together, these results suggest that the FNF and FW motifs 
define ICP8 self-interaction sites required for filament formation and for ICP8 to 
reorganize the nucleus of the infected cell to form PRS and RCs.  
 
Previously, several functions have been mapped to the C-terminus of ICP8: an NLS 
was mapped to the C-terminal 28 residues (Gao and Knipe 1993) and the region 
between amino acid residues 1080-1135 was implicated in interactions with viral or 
cellular factors required for replication compartment formation (T. J. Taylor and Knipe 
2003); however, a detailed biochemical analysis of mutations in this region has never 
been performed. In this study we extend the characterization of this region and show 
that in addition to affecting replication compartment formation, the FNF motif is involved 
in ICP8 self interactions that are required for filament formation.  
 
ICP8 is known to form two types of filaments in vitro, double helical filaments that form 
in the absence of DNA (Makhov et al. 2009) and a single helical filament on ssDNA 
(Makhov and Griffith 2006). A double helical filament might be expected to be stabilized 
by two types of interactions, longitudinal interactions between adjacent subunits in each 
filament and lateral interactions between adjacent filaments. The inability of the FNF 
and FW mutants to form filaments and the trans-dominant inhibition of filament 
formation when mixed with WT ICP8 are consistent with a role for the FNF and FW 
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motifs longitudinal interactions in filament formation. The simplest explanation for these 
results is that the FNF motif docks at the FW motif in an adjacent ICP8 molecule to form 
a linear filament.  
 
Spatial organization within cells is critical for the control of the diverse metabolic 
activities necessary for cell survival, and subcellular compartmentalization provides 
boundaries that facilitate regulation of biological processes. Some processes are 
regulated by the sequestration of components away from one another, while in other 
cases it is beneficial to concentrate components that catalyze essential reactions. 
Although some cellular compartments are defined by membrane enclosure, it is 
becoming increasingly clear that many important subcellular compartments are not 
membrane limited. For instance, in the nucleus, many varieties of membrane-less sub-
organelles are known to play important roles in the special and temporal organization of 
macromolecules, including PML-nuclear bodies, speckles and nucleoli (Kevin Van 
Bortle 2012). The mechanisms by which proteins and nucleic acids are recruited to form 
these non-membrane-delimited microenvironments are poorly understood; however, it 
appears that their formation may be caused by low-affinity, multivalent interactions 
between components (Brangwynne et al. 2009; Brangwynne 2013; Hyman, Weber, and 
Jülicher 2014; C. F. Lee et al. 2013). Proteins and nucleic acids in these sub-organelles 
remain dynamic and mobile, facilitating rapid responses to various types of stimuli.  
 
Viruses that replicate in the nucleus have evolved surprisingly efficient mechanisms to 
form compartments within the densely crowded nuclear environment, which is critical for 
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the establishment of productive infection. The formation of viral subassemblies such as 
PRS and RCs may be driven by similar biophysical principles to those that influence the 
assembly of membrane-less organelles. In this chapter we have established that the 
ability of ICP8 protein to form filaments in solution is correlated with the formation of 
PRS-like foci and RC. We propose that dynamic self-interactions between ICP8 
monomers may facilitate the formation of a scaffold on which PRS and RCs can form. 
The ability of ICP8 to undergo conformational changes upon binding to other HSV 
proteins and/or to DNA has been known for some time (Dudas, Scouten, and Ruyechan 
2001; Uprichard and Knipe 2003a). Uprichard et al. showed that reactivity to a 
conformation specific monoclonal antibody (39S) changes during infection (Uprichard 
and Knipe 2003a). Our transfection experiments indicate that co-expression of ICP8 
with helicase/primase leads to the formation of small punctate foci that resemble PRS, 
while the addition of polymerase and UL42 results in the formation large globular RCs 
(Lukonis and Weller 1997). Taken together these results suggest that ICP8 is dynamic 
and takes on different conformations depending on the presence of other replication 
proteins. It will be important to determine whether the dynamic nature of ICP8 
interactions with itself, with other viral and cellular proteins and with nucleic acids are 
similar to the weak multivalent interactions that contribute to phase separations and the 









ICP8 Mutant Q706A-F707A Can Assemble Pre-replicative Like Sites Although 
Fails to Form Replication Compartments. 
 
Jonathan Helmus contributed to Figure 4.1; he performed the bioinformatics analysis 
and helped identify predicted protein interaction sites on ICP8. All other work in this 




















ICP8 is an essential multifunctional protein that interacts with both viral and cellular 
proteins during the course of an HSV-1 infection. However, the protein interaction sites 
on this protein are completely unknown. In this study we attempted to identify residues 
on ICP8 that might be involved in protein-protein interactions. Using the structural 
information of ICP8 and sequence comparison with homologous proteins, we identified 
a cluster of six conserved amino acids (R644, D645, N882, L883, D905 and Y909) in 
the head region of ICP8 and another set of conversed residues in the shoulder region 
(R262, H266, D270, E271, E274, Q706 and F707) that might function as protein 
interaction sites. We tested these sites by constructing alanine mutations in these 
residues and testing pairs of mutations for complementation of an ICP8 null virus, 
replication compartment formation, and assemble into pre-replicative like sites. Several 
mutations were identified that disrupted ICP8 function; we focused on the Q706A-
F707A  (QF) mutation. The QF mutant protein is able to form pre-replicative like sites 
and bind ssDNA but does not complement ICP8 null virus for growth and replication 
compartment formation. Our characterization suggests the Q706 and F707 residues are 
involved in an important interaction that is required for the progression to mature 







The HSV-1 replication proteins have long been identified although a full 
understanding of the orchestration of protein assembly through protein-protein 
interactions to form replication compartments and assemble the replication fork is still 
lacking. In this study we have chosen to focus on identifying protein interaction sites on 
ICP8, the ssDNA binding protein. ICP8 is an essential protein for viral DNA replication 
and has multiple roles in the viral life cycle; a list of ICP8’s viral interaction partners is 
summarized in Table 4.1. In addition to its single strand DNA binding property, ICP8 can 
stimulate the helicase unwinding activities of UL9 and the helicase-primase activity of 
UL5/8/52 and can regulate polymerase activity (Hamatake, Bifano, Hurlburt, and Tenney 
1997b; Boehmer and Lehman 1993b; Ruyechan and Weir 1984). Mapping the interaction 
domains of ICP8 with the UL5/8/52 complex and with UL9 is of considerable interest, 
because it will improve our understanding of how proteins are assembled and released at 
the replication fork, and might facilitate the design of new antiviral therapies. Furthermore, 
ICP8 interacts with UL12 to form a two-subunit recombinase that can mediate strand 
exchange reactions (Reuven et al. 2004; Reuven, Antoku, and Weller 2004). It is also of 
interest to map the ICP8-UL12 interaction because it will improve our understanding of 
HSV-1 recombination-mediated replication.  
In our previous study, we identified two motifs involved in ICP8-ICP8 self-interactions 
and filament formation. One interaction motif, 1142-1144FNF (FNF motif), was located  
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Table 4.1 Partial list of HSV-1 proteins reported to interact with ICP8 
HSV-1 proteins that 
interact with ICP8 




UL9 Protein affinity 
chromatography 
(Boehmer & Lehman, 
1993) 
UL5/8/52 SPR (Falkenberg, Elias, & 
Lehman, 1998) 
UL12 Co-IP from infected cell 
lysate 
(Thomas, Gao, Knipe, & 
Powell, 1992) 
UL 42 Co-IP from infected cell 
lysate 
(Taylor & Knipe, 2004) 
ICP4 Co-IP from infected cell 
lysate 
(Taylor & Knipe, 2004) 
ICP27 Co-IP from infected cell 
lysate 
 (Zhou & Knipe, 2002) 
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in the C-terminal 60 amino acids and the other was located in a hydrophobic pocket 
formed by residues F843 and W844 (FW motif). Our data supports the hypothesis that 
the FNF motif docks in the FW motif of an adjacent ICP8 molecule to form the 
longitudinal interactions of a linear ICP8 filament (Darwish et al. 2016). ICP8 is likely to 
have additional motifs involved in horizontal self-interactions that stabilize the bilateral 
double filament.  
 
We are interested in uncovering more ICP8-ICP8 interaction sites and mapping 
residues on ICP8 involved in interactions with the other essential replication proteins. In 
addition to viral replication proteins, ICP8 interacts either directly or indirectly with at 
least 50 cellular proteins (T. J. Taylor and Knipe 2004), however no residues on ICP8 
have been identified as  specific interaction sites with any of its partners.  In this study, 
we used a bioinformatic approach to search for potential protein interaction sites on 
ICP8 and identified a cluster of six conserved amino acids (R644, D645, N882, L883, 
D905 and Y909) in the head region of ICP8 and another set of conversed residues in 
the shoulder region (R262, H266, D270, E271, E274, Q706 and F707). We discovered 
that Q706 and F707 amino acid residues are essential for viral growth and are required 
for the formation of mature replication compartments. However, the Q706A-F707A 
mutant did not disrupt ICP8 ability to from pre-replicative like structures.  Further 
experimentation is required to identify the functional role of Q706 and F707 residues in 
the formation of replication compartments and to identify proteins that are interacting 






Identifying potential protein interaction sites on ICP8 
Mapelli et al. suggested several possible protein interaction sites on ICP8 based on the 
protein structure including two conserved pockets (Y20, F61, Y90) and (C116, R120), 
as potential protein interaction sites (Mapelli, Panjikar, and Tucker 2005). We 
incorporated their suggestions and also conducted a further in-depth sequence analysis 
to generate additional potential protein interaction sites.  
 
We conducted a sequence alignment of ICP8 orthologues from representatives of three 
sub families of Herpesviridae, listed in table 4.2, using the t-coffee multiple sequence 
alignment program developed by (Notredame, Higgins, and Heringa 2000). This analysis 
revealed 227 conserved residues in ICP8. We then selected residues that were exposed 
within 10 Å² from the surface using Pymol and excluded residues that have known 
functions or are predicted to be involved in ssDNA binding. At the end of our selection, 
our criteria resulted in 50 candidate residues for potential protein interaction sites. We 
chose to initially focus on residues that were in close proximity to other conserved 
residues and formed a small cluster on the surface of the protein, which could potentially 
act as a protein interaction site (Figure 4.1).   
 
Using this analysis we identified a group of six conserved amino acid residues (R644, 




Table 4.2 ICP8 orthologues from the following Herpesviridae viruses were 
used in a sequence alignment for identifying conserved residues in ICP8.  
 
Alphaherpes viruses  
 
Herpes Simplex Virus-1 (Strain KOS) 
Herpes Simplex Virus-1 (Strain 17)  
Herpes Simplex Virus-2  
Varicella Zoster Virus 
Mareks Virus 










KSHV Kaposi’s Sarcoma Associated Herpesvirus  
EBV Epstein-Barr Virus  






Figure 4.1 Predicted protein interaction sites annotated on ICP8. (A) Bottom and 
(B) side view of ICP8 (PDB ID 1URJ). The following residues are suggested to be involved
in protein interaction; Magenta (Y20, F61, Y90), Cyan (C116, R120), Red (F827, F843, W844,
L857, I865), Dark Blue (R262, H266, D270, Q706, F707, V710) and Green (R644, D645, N882,
L883, D905, Y909). Amino acid residues predicted to be involved in the DNA binding 
activity and the zinc binding motif are represented in yellow and orange respectively. 
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4.1, these residues are situated on the side of the head region that is opposite to the FW 
motif (shown in red). We also identified another group of seven-conserved amino acid 
residues (R262, H266, D270, E271, E274, Q706 and F707) located in the shoulder 
region of ICP8, as shown in dark blue Figure 4.1. These residues might appear to be 
distant from one another based on the primary sequence however the tertiary structural 
folds of ICP8 bring these residues in close proximity to one another.  
To screen if these predicted protein interaction residues are significant targets that 
warrant further investigation, we paired up the conserved residues by proximity to one 
another and introduced alanine substitution mutations in the ICP8 mammalian 
expression vector, as detailed in the materials and methods.  The mutants were 
screened for their ability to perform characteristic ICP8 functions such as; nuclear 
localization, formation of pre-replicative like structures, viral growth and formation of 
replication compartments.    
Characterization of ICP8 head region mutants: (R644A-D645A), (N882A- L883A) 
and (D905A -Y909A) 
The six conserved amino acids (R644, D645, N882, L883, D905 and Y909) in the 
head region of ICP8 were paired into three mutant constructs, R644A-D645A, 
N882A-L883A, and D905A-Y909A. We then introduced double alanine mutations in 
the paired residue sites mentioned above and tested them for complementation with 























































Figure 4.2 Transient complementation of ICP8 null virus by mutant expression
plasmids ICP8 mutants Y20A-F61A-Y90A and Q706A-F707A completely fail to 
complement viral growth, whereas the remaining mutants exhibit varying degrees 
of complementation.  Results are from 3 independent experiments. 
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viral growth. The R644A-D645A and N882A-L883A mutants both partially 
complemented viral growth at values of 54% and 14% respectively (Figure 4.2). The 
D905A-Y909A mutant failed to express a detectable level of protein and was 
excluded from this study (data not shown). 
As discussed previously in Chapters 1 and 3, ICP8 is essential for the formation of 
the earliest detectable pre-replicative sites and can assemble into pre-replicative like 
structures when transfected along with plasmids that express the UL5/8/52 complex. 
ICP8 undergoes a specific change in conformation to form these pre-replicative sites 
(Uprichard and Knipe 2003a). Furthermore, the ability to form these structures is 
correlated with ICP8 filament formation (Darwish et al. 2016). Therefore, testing the 
newly constructed ICP8 mutants for pre-replicative like structure formation can help 
identify mutants of potential interest. 
We found that the R644A-D645A and N882A-L883A mutants were able to localize to 
the nucleus (Figure 4.3) and could still assemble pre-replicative like sites (Figure 4.4). 
Furthermore, both mutants could also complement replication compartment formation 
in the context of a viral infection (Figure 4.5). These mutants appear to have a normal 
phenotype and will not be explored any further in this study; the decrease they 
exhibited in viral growth might be due to loss of an ICP8 function that is not involved 
in replication compartment formation.  
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WT
WT Y20A_F61A_Y90A C116A_R120A R262A_H266A
R644A_D645A Q706A_F707A N882A_L883A
FNF FW_FNF
Figure 4.3 ICP8 mutant Y20A-F61A-Y90A failed to localize to the nucleus.  Vero cells were
 transfected with the indicated ICP8 plasmid, after 20 hours post transfection cells were
xed and stained with a primary ICP8 antibody and a secondary Alexa Fluor 488 antibody.








Figure 4.4 ICP8 Q706A-F707A forms pre-replicative like structures although it is unable to 
complement viral growth. Vero cells were transfected with the indicated ICP8 plasmid and 
(UL5/8/52). At 20 hours post transfection, cells were xed and stained with a primary ICP8 








































Figure 4.5 ICP8-QF was unable to complement replication compartment formation. 
Vero cells were transfected with ICP8 WT or the indicated mutant plasmid. At 16 hours
post-transfection cells were infected with an ICP8 null virus (MOI=20). At 6 hours 
post-infection cells were xed and stained for ICP8 and ICP4 with secondary Alexa Fluor
488 and 594 antibodies, respectively. The immediate early protein ICP4 was used as a 
marker for infection. Only cells that contained both ICP4 and ICP8 were selected for 
analysis. Images were taken with Zeiss LSM 510 confocal microscope.
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Characterization of shoulder region mutants: (Y20A-F61A-Y90A), (C116A-R120A), 
(R262A-H266A), (D270A, E271A, and E274) and (Q706A-F707A).  
Several protein interaction sites have been proposed in the shoulder region of ICP8; 
Mapelli et al. predicted two interaction pockets Y20-F61-Y90 and C116-R120, and 
our analysis predicted a set of conserved residues (R262, H266, D270, E271, E274, 
Q706 and F707). We again used the strategy of pairing residues and constructing 
alanine substitution mutations in these sites. Given the close proximity of (D270, 
E271, and E274) to the other conserved residues in this region we choose to 
postpone studying them to minimize the size of the screen. We initially focued our 
efforts on R262A-H266A, Q706A-F707A and the pockets predicted by Mapelli et.al 
2005. 
The four mutant constructs made in the shoulder region were tested for 
complementation of an ICP8 null virus. Two of the mutants, Y20A-F61A-Y90A and 
Q706A-F707A, completely failed to complement viral growth, whereas the other two 
mutants C116A-R120A and R262A-H266A complemented viral growth at 70% and 
14%, respectively (Figure 4.2). To further characterize the mutants that did not 
complement, we tested if these mutants were correctly localized in the nucleus. We 
found that all of the mutants except for Y20A-F61A-Y90A localized to the nucleus; the 
Y20A-F61A-Y90A mutant was predominantly detected in the cytoplasm (Figure 4.3). 
The nuclear localization signal (NLS) of ICP8 is in the 28 C-terminal residues of the 
protein. However, removal of residues between 17-600 has been shown to affect 
nuclear localization, perhaps by affecting protein conformation or the global folding of 
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the protein (Gao and Knipe 1992a). The Y20-F61-Y90 pocket might be a distal site 
involved in nuclear localization, or perhaps mutating these residues caused global 
misfolding of the protein and it could not be transported to the nucleus; therefore, this 
mutant was excluded from further analysis.  
We next asked if the remaining ICP8 mutants could assemble into pre-replicative like 
structures when transfected along with the helicase-primase complex. We found that 
(C116A-R120A) and (R262A-H266A) mutants, which were also capable of partially 
complementing an ICP8 null virus, could assemble into pre-replicative like structures. 
However, the Q706A-F707A mutant that failed to complement viral growth was still able 
to assemble into pre-replicative like structures as shown in Figure 4.4. This indicates 
that the Q706A-F707A mutation did not affect the structural integrity of ICP8 or its ability 
to form pre-replicative like structures.  
We then tested the mutant constructs for their ability to form replication compartments in 
the context of a viral infection. We found that all of the mutants analyzed were able to 
form replication compartments except for Q706A-F707A, as shown in Figure 4.5. The 
Q706A-F707A mutant may have lost a critical protein interaction partner or a functional 
property of ICP8 required for progression into mature replication compartments.  
Given the unique phenotype of Q706A-F707A we revisited the shoulder region of ICP8 
and made additional alanine substitution mutations in the conserved neighboring 
residues D270, E271 and E274. The new mutants were then tested for their ability to 
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complement the growth of an ICP8 null virus (Figure 4.6). The E274A mutant had the 
most significant effect on viral growth and completely failed to complement; whereas, 
D270A and E271A could both partially complement viral growth. However, a double 
mutant D270A-E271A or triple mutant D270A-E271A-E274A that combines these 
mutated residues together resulted in complete inhibition of viral growth (Figure 4.6). 
These three residues warrant further investigation, they might be part of the same motif 
as Q706A-F707A or they might have an independent function.  It appears that E274 is 
the more significant residue and D270 and E271 might have more of a supporting role.  
More experiments need to be conducted to further characterize the phenotype of these 
mutants and to understand their role in the HSV-1 life cycle.  
ICP8 Q706A- F707A mutant can still bind to ssDNA 
ICP8 is an efficient ssDNA binding protein, and probably interacts with other viral and 
cellular proteins while bound to or in close proximity to DNA. It is possible that the 
Q706A-F707A phenotype observed might be caused by the loss of ssDNA binding. 
Therefore, before attempting to identify a viral or cellular partner that might be binding 











































Figure 4.6 Transient complementation of ICP8 null virus by D270A, E271A and E274A 
mutant expression plasmids. ICP8 mutant E274A is unable to complement viral growth,
 but ICP8 mutants D270A and E271A can partially complement.  Combinations of D270A, 
E271A and E274A can result in a drastic reduction in viral growth.
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The Q706A-F707A mutant was purified from insect cells infected with a recombinant 
baculovirus as previously described (Darwish et al. 2016). The mutant was stable and 
behaved similarly to wild type ICP8 during the purification. A Coomassie stained gel of 
the Q706A-F707A mutant and wild type ICP8 is shown in (Figure 4.7A).   
We then used an electrophoretic mobility shift assay (EMSA) to test whether the mutant 
could still bind to ssDNA. In this assay, wild type or mutant ICP8 protein was incubated 
with a Cy3-labeled 50-nt oligomer, and the reaction products were resolved by 5% 
nondenaturing PAGE (Figure 4.7B). Similar to the wild type, Q706A-F707A bound 
ssDNA in a concentration dependent manner and displayed a faster and slower 
migrating band pattern, which is characteristic of cooperative binding.  
At the higher concentration of 400 nM Q706A-F707A is almost exclusively found in the 
slower migrating band, perhaps this mutant has higher DNA binding affinity or a 
stronger tendency to bind cooperatively. This observation requires further investigation 





In this study, we conducted a small mutational screen of ICP8 with the aim of identifying 
residues that might be involved in protein interactions. We embarked on this study 
without a specific protein interaction target of ICP8 in mind; hence we used broad based 
functional assays of ICP8 such as complementation of viral growth of an ICP8 null virus, 
assemble of pre-replicative like structures and formation of replication compartments to  
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ICP8   Q706A_F707A










Figure 4.7 ICP8 QF mutant retains the ability to interact with ssDNA 
(A) ICP8 wild type and the Q706A_F707A mutant were expressed and puried from 
Sf9 insect cells infected with recombinant baculoviruses and puried as described in 
Materials and Methods. Puried proteins were resolved by 8% SDS-PAGE and stained 
with coomassie blue. 
(B) ICP8 wild type or Q706A_F707A were incubated at the following concentrations 
(0, 50, 100, 200, or 400nM) with 100 nM of 5’ uorescein-labeled 50 nt length ssDNA 
substrate for 30 min and the complexes were separated on 5% nondenaturing
polyacrylamide gels.  ICP8-QF was able to bind DNA cooperatively and was 
comparable to WT. The signal was detected using Bio Rad Chemi-Doc MP
imaging system.
Q706A_F707AICP8   
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screen mutants for anomalies that might indicate loss of an important protein-protein 
interaction. We generated a list of potential protein interaction residues by following a 
mutational design strategy that focused on conservation of residues and their proximity 
to the surface. This selection criterion resulted in 50 potential residues; we focused our 
initial efforts on six residues in the shoulder region and four residues in the head region 
of ICP8 because those residues were in close proximity to one another and formed 
small clusters. Furthermore, we tested two protein interaction pockets (Y20A-F61A-
Y90A) and (C116A-R120A) predicted by Mapelli et. al (Mapelli, Panjikar, and Tucker 
2005). The phenotypes of all the mutants tested in this study are summarized in Table 
4.3; we were particularly interested with the phenotype displayed by the Q706A-F707A 
ICP8 mutant. This mutant was not able to complement viral growth of an ICP8 null virus 
or form replication compartments, although the Q706A-F707A mutant retained the 
ability to bind ssDNA and could still assemble into pre-replicative like structures when 
co-transfected with the helicase-primase complex. Q706A-F707A is the first ICP8 
mutant identified that is able to form pre-replicative like structures but not complement 
the growth of the virus and progress into mature replication compartments. ICP8 is 
thought to undergo a conformational change that coincides with the assembly of pre-
replicative sites (Uprichard and Knipe 2003b). It appears that the Q706A-F707A mutant 
has maintained the ability to commence this conformational change, although further 
investigation with ICP8 specific conformation antibody 39S is required to confirm this. 
Our work has also correlated pre-replicative site formation with ICP8 filament formation, 
as discussed in chapter 3. It would be of interest to determine if recombinant purified 
Q706A-F707A mutant protein could interact with itself to assemble filaments.  
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Table 4.3 Characterization of ICP8 mutants  
 
 




































































































































Although evidence is preliminary, Q706A-F707A might be binding ssDNA with higher 
affinity than wild type ICP8. It would be of interest to further quantify the ssDNA binding 
affinity of this mutant, an increase in binding affinity might explain why Q706A-F707A is 
unable to complement viral growth. It is possible that Q706A-F707A binds DNA too 
strongly to be easily removed from DNA during the progression of the replication fork. 
This mutation might also cause ICP8 to be stuck in a conformation that can bind DNA 
but is unable to interact with UL9 to form the co-complex that is involved in unwinding 
the origin of replication or to stimulate the helicase –primase activity of the UL5/8/52 
complex. Furthermore, the tight DNA binding exhibited by this mutant might also 
interfere with ICP8 annealing activity.  All of these suggestions are still highly 
speculative and require much further investigation into the DNA binding affinity of 
Q706A-F707A and conducting the proper functional biochemical assays.  
 
It would be of interest to explore proteins that are known to both interact with ICP8 and 
are involved in the early steps of pre-replicative site assembly. Such candidates include 
the immediate early proteins ICP4 and ICP27 as well as early proteins UL9 and 
UL/5/8/52. This study was successful in identifying residues of potential interest in ICP8, 
although much further investigation into the phenotype of Q706A-F707A is required to 
provide an understanding of the exact role of these residues. Furthermore, the D270, 
E271 and E274 residues are promising candidates for further investigation. Our initial 
analysis has shown that mutations in these sites drastically effect the complementation 
of an ICP8 null virus. The close proximity of these residues to Q706A-F707A might 
indicate that they are either a part of this motif or they might have a supporting 
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functional role. More work is needed in characterizing the phenotype of these mutants 

























Summary and Perspectives 
 
The HSV-1 ssDNA binding protein, ICP8, has numerous roles during HSV-1 
replication and is a central component of replication compartment formation. ICP8 and 
the other viral replication proteins have been studied for several decades and much 
progress has been made; although, a full understanding of the DNA replication 
mechanism is still lacking. Moreover, a complete picture of how proteins are recruited to 
assemble the prereplicative scaffolds that mature into replication compartments is also 
not clear. To address some of these gaps in our knowledge we focused our efforts on 
understanding the protein interaction interface of the ssDNA binding protein. We were 
particularly interested in exploring ICP8 self-interactions that are involved in filament 
formation. ICP8 double helical protein filaments are expected to have both lateral and 
linear self-interactions that are involved in stabilizing the filament.  
 
The work presented in this thesis addressed the biological role of DNA independent 
ICP8 filaments and successfully mapped the linear protein interaction sites between two 
adjacent ICP8 molecules. Our findings established a correlation between ICP8 
filamentation and the formation of replication compartments. Furthermore, we were able 
to make predictions about ICP8’s interaction surface and identified several potential 
protein interaction sites. The mutants identified in this work have potentially opened the 





ICP8 filament formation is required for replication compartment formation in HSV 
 
Most viruses reorganize the cellular space to maximize their own productive efficiency, 
usurp cellular recourses and evade the host defense response. Viruses have evolved to 
form complex molecular assembles in either the cellular or nuclear space referred to as 
either replication compartments/ centers/ complexes, virus factories or viroplasms. 
These macromolecular assemblies create a space in which viral replication proteins can 
be concentrated with viral genomes, host proteins required for replication while also 
being physical separated from the cellular antiviral defenses.  
 
Viruses that replicate their genomes in the cytoplasmic space form replication 
compartments that require changes in the distribution and dynamics of the cytoskeleton 
along with reorganization of organelles such as the Golgi apparatus, endoplasmic 
reticulum, endosomes, lysosomes and mitochondria (Schmid et al. 2014).  Some 
positive-strand RNA viruses for instance, create single or double membranous 
replication compartments in the cytoplasm (Paul and Bartenschlager 2013).  On the 
other hand, DNA viruses that replicate in the nucleus do not form membrane bound 
compartments although they require reorganization of the nucleus in several different 
ways such as redistribution of chromatin, nuclear domains (ND-10), Cajal bodies (CB) 





As discussed in Chapters 1 and 3, HSV-1 causes dramatic reorganization of the nuclear 
space and forms membrane-less replication compartments. The first aim of this thesis 
was focused on understanding the involvement of ICP8 filaments in the formation of 
replication compartments. ICP8 is known to form at least two types of filaments; it can 
form single helical filaments on ssDNA and it can also form double helical filaments in 
the absence of DNA. We were interested in exploring the biological significance of 
ICP8’s self-interactions that are involved in filament formation. Our work established a 
correlation between ICP8 filament formation and replication compartment formation. 
ICP8 filaments might be involved in acting as a scaffold that stores and recruits factors 
that are important for DNA replication. It is important to note that our cell-based 
experiments could not discriminate between the two different types of ICP8 filaments. 
More work is still needed in this area and both types of filaments are likely to be 
involved in replication compartment formation.  
 
ICP8 filament formation is not unique among ssDNA binding proteins in the 
Herpesviridae family. ICP8 homologs BALF2 and ORF6, Epstein-Barr virus (EBV) and 
Kaposi’s sarcoma-associated herpesvirus (KSHV) ssDNA binding proteins, respectively, 
also form DNA-free helical protein filaments (Ozgur, Damania, and Griffith 2011; 
Mumtsidu, Makhov, and Konarev 2008). BALF2 and ORF6 are also important 
components of replication compartment formation (Daikoku et al. 2005; F. Y. Wu et al. 
2001). These systems have not been studied as well as HSV-1; therefore, our 
observations about ICP8 filament formation may lead the path to understanding 
filamentation in other members of the Herpesviridae family as well. 
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Moreover, the possible involvement of protein filaments or fiber like structures in 
manipulating the nuclear space is not only observable in HSV-1. Other viruses such as 
Adenoviruses have been reported to employ nuclear fiber-like structures, formed by 
E1B-55K and E4-ORF3 proteins, to create a multivalent scaffold that disrupts and 
usurps SUMO2/3 interactions thereby transforming the nucleus and forming 
compartmentalized viral genome domains (Ou et al. 2012).  
 
There are still many unanswered questions regarding the role of filamentation in HSV-1 
replication compartment formation. We were only able to correlate filaments with 
replication compartment formation; however, we do not know if DNA independent 
filaments of ICP8 can be visualized within these structures. We also do not understand 
all the elements that are driving the formation of replication compartments within the 
nucleus. We demonstrated that ICP8 self-interactions are important but have not shown 
that these are sufficient. It will be of considerable interest to determine whether 
additional factors are required for ICP8 to adopt the conformations that are observed in 
pre-replicative sites and replication compartments. In vitro experiments using purified 
ICP8 protein showed that ICP8 could assemble into filaments without the assistance of 
any other proteins. However, pre-replicative-like sites in a cell are efficiently generated 
when the helicase-primase complex accompanies ICP8. In chapter 3 we showed that 
mutants in the FNF and FW motifs of ICP8 can still interact with the helicase-primase 
complex but failed to generate pre-replicative like sites, suggesting that both ICP8 self 
interactions and ICP8’s interaction with the helicase-primase complex are required 
simultaneously for the generation of pre-replicative-like sites.  
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The earliest detectable viral structures in a cell after infection are small foci containing 
the immediate early proteins ICP4 and ICP27. The earliest detectable ICP8 containing 
pre-replicative sites form adjacent to the ICP4/ICP27 foci and the formation of ICP8 pre-
replicative sites is severely reduced in the presence of an ICP4 mutant that fails to 
oligomerize on viral DNA (Livingston et al. 2008). It would be of interest to further 
explore the relationship between ICP4 and ICP8 during these early stages. Is there a 
connection between ICP4 oligomerization and ICP8 filamentation? ICP8 is also known 
to physical interact with both ICP4 and ICP27; it would be of interest to test if the FNF 
and FW motifs are somehow involved in this interaction. 
 
Identification of potential protein interaction sites on ICP8  
 
The second aim of this thesis focused on identifying protein interaction sites on ICP8.  
The HSV-1 ssDNA binding protein has been studied for several decades but no protein 
interaction motifs have been mapped on ICP8. This is mostly attributed to ICP8’s 
noncontiguous structure, residues in ICP8 that are seemingly distant in the linear 
sequence can be close to each other in the tertiary structure, thus past efforts at making 
deletions and truncations in this protein have not been very informative. In order to map 
residues involved in protein –protein interactions, we decided to make predictions based 
on identifying conserved residues on the surface of the protein. In chapter 4, we 
reported a cluster of six conserved amino acids (R644, D645, N882, L883, D905 and 
Y909) in the head region of ICP8 and another set of conversed residues in the shoulder 
region (R262, H266, D270, E271, E274, Q706 and F707). The Q706-F707 (QF) 
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residues displayed the most striking phenotype of all of the mutants tested. This mutant 
was able to assemble into pre-replicative-like sites and could still bind ssDNA but was 
unable to complement the growth of an ICP8 null virus.  
 
The QF mutant is the first isolated mutant of ICP8 that preserves the ability to assemble 
into pre-replicative-like structures while also failing to complement HSV-1 growth. This 
suggests a partially functional ICP8 mutant that has maintained some critical functions 
of the protein while also losing a vital property. There are several possibilities that could 
explain this phenotype; perhaps QF is unable to interact with or stimulate the function of 
a critical viral protein partner or an unknown cellular partner. This mutant may have also 
lost an intrinsic functional property of ICP8 required for the progression of viral DNA 
synthesis and full replication compartment formation. 
  
  ICP8 is known to be involved in many aspects retaining to HSV-1 replication. It is 
involved in unwinding the origin of replication with UL9 and it is also required to 
stimulate the helicase-primase activity of UL5/8/52. Furthermore, ICP8 is involved in 
stimulating the polymerase activity of UL30 and is required for the elongation of newly 
synthesized DNA. Additionally, ICP8 has annealing activity and functions as a two-
subunit recombinase with the virally encoded exonuclease, UL12 (Reuven et al. 2003; 
Reuven et al. 2004; Dutch and Lehman 1993).  All of the functions of ICP8 listed above 
are very important but no residues on ICP8 have been specifically mapped as 
responsible for these functions. The QF mutant might provide an opportunity for us to 
map an important ICP8 functional domain.  
90
	 	
Since the completion of the work described in Chapter 4, additional studies from the 
Weller lab have shown that the QF mutant preserved the ability to assemble into DNA 
independent filaments (Weerasooriya, unpublished). This result suggests that the QF 
mutant is not involved in ICP8 self-interactions required to form filaments in the absence 
of DNA. Additionally, the functional relationship between QF and the other viral 
replication proteins was explored.  WT ICP8 has been shown to stimulate ssDNA 
dependent ATPase activity of UL9, the origin unwinding protein (Boehmer 1998). 
Interestingly QF resembled WT in its ability to stimulate UL9 (DiScipio, unpublished). 
This finding indicates that the QF mutant protein is probably capable of interacting with 
UL9, although the interaction between these two proteins was not tested directly.  
 
Furthermore, the QF mutant retained the ability to function as a ssDNA binding protein 
and could cooperatively bind to a ssDNA template. This mutant could also stimulate in 
vitro DNA synthesis of a mini circle DNA template in a reaction along with the viral 
helicase-primase complex and the polymerase complex. The levels of DNA synthesis 
observed in this assay were similar to those of wild type ICP8 (Weerasooriya, 
unpublished). Interestingly, HSV-1 infected cells showed that this mutant does not have 
any traces of viral DNA synthesis (Weerasooriya, unpublished). It is important to note 
that the mini circle assay does not require UL9 and the DNA template used in this 
reaction do not have a viral origin of replication. Origin dependent DNA replication of 
HSV-1 has never been recapitulated in vitro. The mini circle assay is the best available 
option for testing HSV-1 replication proteins for in vitro DNA synthesis. QF’s ability to 
stimulate DNA synthesis with the mini circle assay indicates that this mutant has 
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retained the ability to stimulate both the helicase-primase complex and the polymerase 
complex. Although, the possible involvement of QF during the early initiation steps of 
origin unwinding has not been tested. As discussed in chapter 1, ICP8 plays an 
important role during origin unwinding with UL9. Electron microscopy experiments have 
reported that UL9 and ICP8 can unwind a plasmid containing an HSV-1 origin 
(OriS)(Makhov et al. 2003). It may be of interest to test if QF and UL9 could unwind an 
OriS containing plasmid. A deficiency during this step might explain the failure of the QF 
mutant to complement an ICP8 null virus and it’s inability to produce viral DNA in the 
context of an infection. However, QF’s ability to successfully stimulate UL9’s ATPase 
activity is a promising indicator that it might be able to unwind an OriS containing 
plasmid. 
 
As mentioned earlier, ICP8 is also known to function as an annealase and is thought to 
form a two-subunit recombinase with UL12, the viral exonuclease (Reuven et al. 2003; 
Reuven et al. 2004; Dutch and Lehman 1993). Recombination is thought to play a role 
during HSV-1 replication because the DNA product is a highly branched and longer than 
unit length concatemer (reviewed in ((Wilkinson and Weller 2003; Weller and Sawitzke 
2014)).  The annealing property of QF was tested and the mutant failed to stimulate an 
annealing reaction between two complementary strands of DNA (Weerasooriya, 
unpublished). It would be of interest to determine the mechanism by which the QF motif 
is involved in the annealing reaction.  
Furthermore, the FNF and FW mutants are also deficient in annealing activity (Grady, 
unpublished). The inability of FNF and FW mutants to anneal may be attributed to their 
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lack of cooperative binding on ssDNA or due to the involvement of these motifs in 
filament formation. However, we only explored FNF and FW mutants for filament 
formation in the absence of DNA. It would be of interest to test FNF and FW for filament 
formation on ssDNA and to monitor the annealing reaction under electron microscopy 
because ICP8 filament formation on ssDNA has been shown to be an intermediate in 
the annealing reaction (Makhov and Griffith 2006).  
 
 We have identified three ICP8 mutants that completely fail to complement viral growth 
and also fail to stimulate an annealing reaction. Are all three of these ICP8 motifs 
involved in annealing? A further in depth analysis is required to understand the steps 
involved in ICP8 annealing reaction. It is possible that the FNF and FW motifs are not 
effecting annealing directly but only as a byproduct of other deficiencies. The QF motif 
might have more of a direct involvement in the annealing reaction but more mechanism 
studies are still needed.  
 
  Concluding thoughts and future direction:  
 
The work presented in this thesis has enhanced our understanding of the role of ICP8 in 
replication compartment formation. The isolation of the FW and FNF mutants described 
in Chapter 3 has provided insight into requirements for the ICP8-ICP8 interaction 
needed for the formation of helical ICP8 filaments in the absence of DNA.  The QF 
mutant described in Chapter 4 was able to form filaments both in the absence and 
presence of DNA and yet exhibited an interesting defect in annealing complementary 
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strands. ICP8 plays many roles in the HSV life cycle, and is believed to be important for 
initiation of DNA synthesis and elongation. ICP8 has also been shown to play a role in 
recombination. It has never been possible to separate residues involved in replication 
from those needed for recombination.  The QF mutant is of particular interest because it 
provides a potential opportunity to separate the roles of ICP8 in replication and 
recombination.   
 
Future work is required to map additional ICP8 self-interactions that are involved in 
filament formation and to understand the mechanism by which ICP8 filaments are 
involved in the formation of replication compartments. As mentioned earlier, ICP8 
double helical filaments are expected to have both lateral and linear interaction sites. 
The work presented in this thesis focused on mapping the linear ICP8 self-interactions. 
It would be of interest to also map the lateral interaction sites that occur between ICP8 
molecules. A more detailed understanding of ICP8 self-interactions may contribute to 
understanding how filamentation is involved in replication compartment formation. It 
would also be of interest to understand the conformational changes that are occurring 
with ICP8 during the formation of pre-replicative sites. It is also suggested to test FNF 
and FW mutants for their interactions and involvement with other replication proteins. 
For instance, it would be of interest to determine if the FNF and FW mutants can 
stimulate the elongation of DNA synthesis via the mini-circle assay. If these mutants can 
sustain in vitro DNA synthesis, it might support the hypothesis that ICP8-ICP8 




Studying the ICP8-UL9 physical interaction is also of interest because it would 
contribute to our understanding or viral origin unwinding. Preliminary findings suggest 
that UL9 interacts with ICP8 through the FW motif in the head region of ICP8 (DiScipio, 
unpublished). It is interesting that the UL9-ICP8 interaction and the ICP8-ICP8 
interaction occur through a shared motif and are possibly competing for the same 
interaction site. This fits with a model proposed by Mapelli et al, in which the ICP8-UL9 
interaction is necessary to successfully unwind the origin but is then exchanged for 
ICP8-ICP8 intermolecular interactions for the commencement of replication and the 
release of UL9 from the origin (Mapelli, Panjikar, and Tucker 2005). Furthermore, given 
the complex interaction and interplay between ICP8- UL9 during origin unwinding; it is 
possible that there are also other interaction motifs between these two proteins.  
 
 A comprehensive mapping of the ssDNA binding sites on ICP8 would also supplement 
our understanding of this proteins activity. Detailed predictions about the residues 
involved in ssDNA binding have been suggested based on the protein structure 
(Mapelli, Panjikar, and Tucker 2005). It would be advisable to test the validity of these 
predictions and to also search for secondary DNA binding sites on ICP8.  
 
  The QF mutant was initially made in an attempt to understand protein interaction 
motifs in ICP8; it was an unanticipated finding that this mutant was defective in 
annealing activity. It might still be of interest to test the QF mutant for protein 
interactions with other critical viral factors. There are also residues in the vicinity of the 
QF motif such as D270, E271 and E274 that might be involved in protein interactions.  
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Preliminary studies with these mutants have shown a drastic deficit in complementation 
of an ICP8 null virus; these residues warrant further investigation. It would be of interest 
to characterize the phenotype of these mutants and to test them for their ability to form 
pre-replicative-like structures, bind ssDNA and assemble filaments. Given the proximity 
of D270, E271 and E274 to the QF motif it might also be of interest to test if these 
residues are part of the motif involved in annealing activity. It’s possible that these 
residues might be involved in the physical interaction between ICP8 and UL12- enabling 
them to function as a two-subunit recombinase.  
 
The work presented in this thesis has enriched our understanding of replication 
compartment formation and has narrowed the search for potential protein interaction 
sites on ICP8. Much work is still needed in the coming years to provide explanations for 
the mechanistic functions of ICP8 filaments in the formation of replication 
compartments. Furthermore, this work has made contributions to our understanding of 
ICP8 annealing functions and has opened the door to improving our understanding of 
the mechanisms involved in HSV-1 recombination-mediated replication.  ICP8 has been 
a fascinating protein to study. Hopefully continued research in this area will prove to be 
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